Napco Security (NSSC) 10-Q3 Feb 252025 Q2 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Dec. 31, 2024	Jan. 31, 2025
Document And Entity Information
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2024
Securities Act File Number	0-10004
Entity Registrant Name	NAPCO SECURITY TECHNOLOGIES, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2277818
Entity Address, Address Line One	333 Bayview Avenue
Entity Address, City or Town	Amityville
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11701
City Area Code	631
Local Phone Number	842-9400
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	NSSC
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000069633
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		36,401,421

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 86,019	$ 65,341
Investments - other		26,980
Marketable securities	13,176	5,398
Accounts receivable, net of allowance for credit losses of $20 and $32 as of December 31, 2024 and June 30, 2024, respectively	23,456	31,898
Inventories	37,634	34,804
Income tax receivable	1,195	73
Prepaid expenses and other current assets	3,252	4,269
Total Current Assets	164,732	168,763
Inventories - non-current	12,040	15,109
Property, plant and equipment, net	9,915	9,077
Intangible assets, net	3,445	3,602
Deferred income taxes	7,012	5,428
Operating lease - Right-of-use asset	5,335	5,487
Other assets	205	286
TOTAL ASSETS	202,684	207,752
CURRENT LIABILITIES
Accounts payable	4,551	7,977
Accrued expenses	8,680	10,345
Accrued salaries and wages	4,032	3,907
Dividend payable	4,554
Total Current Liabilities	21,817	22,229
Accrued income taxes	1,223	1,122
Operating lease liability	5,417	5,512
TOTAL LIABILITIES	28,457	28,863
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS' EQUITY
Common Stock, par value $0.01 per share; 100,000,000 shares authorized as of December 31, 2024 and June 30, 2024; 39,771,035 and 39,768,186 shares issued; and 36,401,421 and 36,874,471 shares outstanding, respectively.	398	398
Additional paid-in capital	24,523	23,712
Retained earnings	186,788	174,300
Less: Treasury Stock, at cost (3,369,614 and 2,893,715 shares as of December 31, 2024 and June 30, 2024, respectively)	(37,529)	(19,521)
Accumulated other comprehensive income	47
TOTAL STOCKHOLDERS' EQUITY	174,227	178,889
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 202,684	$ 207,752

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)
Allowance for credit losses	$ 20,000	$ 32,000
Common stock, par (per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	100,000,000	100,000,000
Common stock, issued (in shares)	39,771,035	39,768,186
Common stock, outstanding (in shares)	36,401,421	36,874,471
Treasury stock, shares	3,369,614	2,893,715

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Net sales:
Net sales	$ 42,933,000	$ 47,547,000	$ 86,936,000	$ 89,223,000
Cost of sales:
Cost of sales	18,444,000	22,535,000	37,831,000	41,798,000
Gross Profit	24,489,000	25,012,000	49,105,000	47,425,000
Operating expenses:
Research and development	3,107,000	2,542,000	6,164,000	4,979,000
Selling, general, and administrative expenses	10,211,000	8,665,000	19,914,000	17,086,000
Total Operating Expenses	13,318,000	11,207,000	26,078,000	22,065,000
Operating Income	11,171,000	13,805,000	23,027,000	25,360,000
Other income:
Interest and other income, net	921,000	729,000	2,065,000	1,169,000
Income before Provision for Income Taxes	12,092,000	14,534,000	25,092,000	26,529,000
Provision for Income Taxes	1,625,000	1,924,000	3,440,000	3,441,000
Net Income	$ 10,467,000	$ 12,610,000	$ 21,652,000	$ 23,088,000
Income per share:
Basic (in dollars per share)	$ 0.29	$ 0.34	$ 0.59	$ 0.63
Diluted (in dollars per share)	$ 0.28	$ 0.34	$ 0.59	$ 0.62
Weighted average number of shares outstanding:
Basic (in shares)	36,538,000	36,829,000	36,706,000	36,743,000
Diluted (in shares)	36,776,000	37,018,000	36,983,000	36,962,000
Equipment
Net sales:
Net sales	$ 21,725,000	$ 29,007,000	$ 44,642,000	$ 53,398,000
Cost of sales:
Cost of sales	16,606,000	20,656,000	34,116,000	38,153,000
Services
Net sales:
Net sales	21,208,000	18,540,000	42,294,000	35,825,000
Cost of sales:
Cost of sales	$ 1,838,000	$ 1,879,000	$ 3,715,000	$ 3,645,000

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)
Net Income (Loss)	$ 10,467	$ 12,610	$ 21,652	$ 23,088
Other comprehensive income, net of tax
Net change in unrealized gains on available-for-sale debt securities, net of taxes of $7	47		47
Other comprehensive income, net of tax	47		47
Comprehensive income	$ 10,514	$ 12,610	$ 21,699	$ 23,088

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)
Net change in unrealized gains on available-for-sale debt securities, net of taxes	$ 7	$ 7	$ 7	$ 7

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income	Total
Balance at Jun. 30, 2023	$ 397	$ 21,553	$ (19,521)	$ 137,740		$ 140,169
Balance (in shares) at Jun. 30, 2023	39,663,812
Treasury Stock, beginning balance (in shares) at Jun. 30, 2023			(2,893,715)
Net income				10,478		10,478
Stock-based compensation expense		307				307
Cash dividend				(2,942)		(2,942)
Balance at Sep. 30, 2023	$ 397	21,860	$ (19,521)	145,276		148,012
Balance (in shares) at Sep. 30, 2023	39,663,812
Treasury Stock, ending balance (in shares) at Sep. 30, 2023			(2,893,715)
Balance at Jun. 30, 2023	$ 397	21,553	$ (19,521)	137,740		140,169
Balance (in shares) at Jun. 30, 2023	39,663,812
Treasury Stock, beginning balance (in shares) at Jun. 30, 2023			(2,893,715)
Net income						23,088
Balance at Dec. 31, 2023	$ 397	22,163	$ (19,521)	154,945		157,984
Balance (in shares) at Dec. 31, 2023	39,675,704
Treasury Stock, ending balance (in shares) at Dec. 31, 2023			(2,893,715)
Balance at Sep. 30, 2023	$ 397	21,860	$ (19,521)	145,276		148,012
Balance (in shares) at Sep. 30, 2023	39,663,812
Treasury Stock, beginning balance (in shares) at Sep. 30, 2023			(2,893,715)
Net income				12,610		12,610
Stock-based compensation expense		303				303
Stock options exercised (in shares)	11,892
Cash dividend				(2,941)		(2,941)
Balance at Dec. 31, 2023	$ 397	22,163	$ (19,521)	154,945		157,984
Balance (in shares) at Dec. 31, 2023	39,675,704
Treasury Stock, ending balance (in shares) at Dec. 31, 2023			(2,893,715)
Balance at Jun. 30, 2024	$ 398	23,712	$ (19,521)	174,300		$ 178,889
Balance (in shares) at Jun. 30, 2024	39,768,186
Treasury Stock, beginning balance (in shares) at Jun. 30, 2024			(2,893,715)			(2,893,715)
Net income				11,185		$ 11,185
Stock-based compensation expense		371				371
Stock options exercised		54				54
Stock options exercised (in shares)	2,849
Purchase of treasury shares			$ (7,280)			$ (7,280)
Purchase of treasury shares (in shares)			(193,252)			(193,252)
Cash dividend				(4,610)		$ (4,610)
Balance at Sep. 30, 2024	$ 398	24,137	$ (26,801)	180,875		178,609
Balance (in shares) at Sep. 30, 2024	39,771,035
Treasury Stock, ending balance (in shares) at Sep. 30, 2024			(3,086,967)
Balance at Jun. 30, 2024	$ 398	23,712	$ (19,521)	174,300		$ 178,889
Balance (in shares) at Jun. 30, 2024	39,768,186
Treasury Stock, beginning balance (in shares) at Jun. 30, 2024			(2,893,715)			(2,893,715)
Net income						$ 21,652
Other comprehensive income, net of tax						$ 47
Purchase of treasury shares (in shares)						(475,899)
Balance at Dec. 31, 2024	$ 398	24,523	$ (37,529)	186,788	$ 47	$ 174,227
Balance (in shares) at Dec. 31, 2024	39,771,035
Treasury Stock, ending balance (in shares) at Dec. 31, 2024			(3,369,614)			(3,369,614)
Balance at Sep. 30, 2024	$ 398	24,137	$ (26,801)	180,875		$ 178,609
Balance (in shares) at Sep. 30, 2024	39,771,035
Treasury Stock, beginning balance (in shares) at Sep. 30, 2024			(3,086,967)
Net income				10,467		10,467
Other comprehensive income, net of tax					47	47
Stock-based compensation expense		386				386
Purchase of treasury shares			$ (10,728)			$ (10,728)
Purchase of treasury shares (in shares)			(282,647)			(282,647)
Cash dividend				(4,554)		$ (4,554)
Balance at Dec. 31, 2024	$ 398	$ 24,523	$ (37,529)	$ 186,788	$ 47	$ 174,227
Balance (in shares) at Dec. 31, 2024	39,771,035
Treasury Stock, ending balance (in shares) at Dec. 31, 2024			(3,369,614)			(3,369,614)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (unaudited)
Cash dividend declared (in dollars per share)	$ 0.125	$ 0.125	$ 0.08	$ 0.08

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 21,652,000	$ 23,088,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,133,000	1,088,000
Interest (income) expense on other investments	(194,000)	(17,000)
Unrealized (gain) loss on marketable securities	(82,000)	(71,000)
(Recovery of) credit losses	(12,000)	(35,000)
Change to inventory reserve	(184,000)	720,000
Deferred income taxes	(1,584,000)	(1,405,000)
Stock based compensation expense	757,000	610,000
Changes in operating assets and liabilities:
Accounts receivable	8,454,000	(1,448,000)
Inventories	422,000	(5,005,000)
Prepaid expenses and other current assets	1,017,000	(124,000)
Income tax receivable	(1,129,000)	(292,000)
Other assets	81,000	20,000
Accounts payable, accrued expenses, accrued salaries and wages, accrued income taxes	(4,807,000)	1,564,000
Net Cash Provided by Operating Activities	25,524,000	18,693,000
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant, and equipment	(1,814,000)	(682,000)
Purchases of marketable securities	(7,642,000)	(117,000)
Purchases of other investments	(78,000)	(655,000)
Redemption of other investments	27,252,000
Net Cash Provided by (Used in) Investing Activities	17,718,000	(1,454,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from stock option exercises	54,000
Cash paid for dividend	(4,610,000)	(5,883,000)
Cash paid for purchase of treasury shares	(18,008,000)
Net Cash Used in Financing Activities	(22,564,000)	(5,883,000)
Net increase in Cash and Cash Equivalents	20,678,000	11,356,000
CASH AND CASH EQUIVALENTS - Beginning	65,341,000	35,955,000
CASH AND CASH EQUIVALENTS - Ending	86,019,000	47,311,000
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	15,000	4,000
Income taxes paid	6,051,000	$ 5,165,000
Non-Cash Investing and Financing Transactions
Cash dividends declared and not paid	$ 4,554,000

Nature of Business and Summary

Nature of Business and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2024
Nature of Business and Summary of Significant Accounting Policies
Nature of Business and Summary of Significant Accounting Policies	NOTE 1 - Nature of Business and Summary of Significant Accounting Policies Nature of Business : Napco Security Technologies, Inc (“NAPCO”, “the Company”, “we”, “our”) is one of the leading manufacturers and designers of high-tech electronic security devices, cellular communication services for intrusion and fire alarm systems as well as a leading provider of school safety solutions. We offer a diversified array of security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. These products are used for commercial, residential, institutional, industrial and governmental applications, and are sold worldwide principally to independent distributors, dealers and installers of security equipment. We have experienced significant growth in recent years, primarily driven by our recurring service revenues generated from wireless communication services for intrusion and fire alarm systems, as well as our school security products that are designed to meet the increasing needs to enhance school security as a result of on-campus shooting and violence in the U.S. Significant Accounting Policies : Principles of Consolidation The consolidated financial statements include the accounts of Napco Security Technologies, Inc. and its wholly-owned subsidiaries. All inter-company balances and transactions have been eliminated in consolidation. Accounting Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We continuously evaluate our estimates and judgments based on historical experience, as well as other factors that we believe to be reasonable under the circumstances. The results of our evaluation form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Critical estimates include management’s judgments associated with reserves for sales returns and allowances, allowance for credit losses, overhead expenses applied to inventory, inventory reserves, valuation of intangible assets, share based compensation and income taxes. These estimates may change in the future if underlying assumptions or factors change, and actual results may differ from these estimates. Fair Value of Financial Instruments The methods and assumptions used to estimate the fair value of the following classes of financial instruments were: Current Assets and Current Liabilities - The carrying amount of cash and cash equivalents, certificates of deposits, marketable securities, current receivables and payables and certain other short-term financial instruments approximate their fair value as of December 31, 2024 and June 30, 2024 due to their short-term maturities. Cash and Cash Equivalents and Investments – other All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit, U.S. treasury securities and time deposit accounts. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. Cash and cash equivalents include approximately $74,620,000 of short-term time deposits, consisting of money market funds totaling $72,095,000 and $2,525,000 of U.S. treasury securities as of December 31, 2024. Cash and cash equivalents include approximately $46,518,000 of short-term time deposits, consisting of certificates of deposit totaling $5,402,000 and $41,116,000 in a money market fund as of June 30, 2024. The Company classifies these highly liquid investments with original maturities of three months or less as cash equivalents. Certificates of deposit with an original maturity greater than three months are classified as Investments-other. Cash and cash equivalents consist of the following as of (in thousands): December 31, 2024 June 30, 2024 Cash $ 11,399 $ 18,823 Money Market Fund 72,095 41,116 U.S. Treasury Securities 2,525 — Certificate of Deposits — 5,402 $ 86,019 $ 65,341 Investments-other consists of the following as of (in thousands): December 31, 2024 June 30, 2024 Certificate of Deposits $ — $ 26,980 $ — $ 26,980 Certificates of deposit are recorded at the original cost plus accrued interest. There were no certificate of deposits outstanding at December 31, 2024. The Company’s certificates of deposits as of June 30, 2024 consist of the following (in thousands): June 30, 2024 Balance Sheet Classification Interest Rate Maturity Date Cost Carrying Value Cash and Cash Equivalents 4.70% 8/22/2024 $ 5,374 $ 5,402 Investments - other 4.55% - 4.75% 7/25/2024 - 10/24/2024 26,709 26,980 The Company has cash balances in banks in excess of the maximum amount insured by the FDIC and other international agencies as of December 31, 2024 and June 30, 2024. The Company has not historically experienced any credit losses with balances in excess of FDIC limits. Marketable Securities Investments in debt securities are classified as available-for-sale and realized gains and losses are recorded using the specific identification method. Changes in fair value, excluding credit losses and impairments, are recorded in other comprehensive income. Fair value is calculated based on publicly available market information or other estimates determined by management. If the cost of an investment exceeds its fair value, the Company evaluates, among other factors, general market conditions, credit quality of debt instrument issuers, and the extent to which the fair value is less than cost. To determine credit losses, a systematic methodology is employed that considers available quantitative and qualitative evidence. In addition, specific adverse conditions are considered related to the financial health of, and business outlook for, the investee. If the Company plans to sell the security or it is more likely than not that the Company will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in other income (expense), net and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments. Investments in equity securities with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). The Company performs a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expense), net. Accounts Receivable Accounts receivable is stated net of the reserves for credit losses of $20,000 and $32,000 as of December 31, 2024 and June 30, 2024, respectively. In accordance with ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326), the Company recognizes an allowance for credit losses for trade receivables to present the net amount expected to be collected as of the balance sheet date. Such allowance is based on the credit losses expected to arise over the life of the asset which includes consideration of past events and historical loss experience, current events and also future events based on our expectation as of the balance sheet date. Receivables are written off when the Company determined that such receivables are deemed uncollectible. The Company pools its receivables based on similar risk characteristics in estimating its expected credit losses. In situations where a receivable does not share the same risk characteristics with other receivables, the Company measures those receivables individually. The Company also continuously evaluates such pooling decisions and adjusts as needed from period to period as risk characteristics change. The Company utilizes the loss rate method in determining its lifetime expected credit losses on its receivables. This method is used for calculating an estimate of losses based primarily on the Company’s historical loss experience. In determining its loss rates, the Company evaluates information related to its historical losses, adjusted for current conditions and further adjusted for the period of time that can be reasonably forecasted. Qualitative and quantitative adjustments related to current conditions and the reasonable and supportable forecast period consider all the following: past due receivables, the customer creditworthiness, changes in the terms of receivables, effect of other external forces such as competition, and legal and regulatory requirements on the level of estimated credit losses in the existing receivables. Inventories Inventories are valued at the lower of cost or net realizable value, with cost being determined on the first-in, first-out (FIFO) method. The reported net value of inventory includes finished saleable products, work-in-process and raw materials that will be sold or used in future periods. Inventory costs include raw materials, direct labor and overhead. The Company’s overhead expenses are applied based, in part, upon estimates of the proportion of those expenses that are related to procuring and storing raw materials as compared to the manufacture and assembly of finished products. These proportions, the method of their application, and the resulting overhead included in ending inventory, are based in part on subjective estimates and actual results could differ from those estimates. The Company records a reserve for excess and slow-moving inventory, which represents any excess of the cost of the inventory over its estimated realizable value. This reserve is calculated using an estimated excess and slow-moving percentage applied to the inventory based on age, historical trends, product life cycle, requirements to support forecasted sales, and the ability to find alternate applications of its raw materials and to convert finished product into alternate versions of the same product to better match customer demand. In addition, and as necessary, the Company may establish specific reserves for future known or anticipated events. There is inherent professional judgment and subjectivity made by both production and engineering members of management in determining the estimated excess and slow-moving percentage (See Note 6). The Company also regularly reviews the period over which its inventories will be converted to sales. Any inventories expected to convert to sales beyond 12 months from the balance sheet date are classified as non-current. Property, Plant, and Equipment Property, plant, and equipment are carried at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred; costs of major renewals and improvements are capitalized. At the time property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and accumulated depreciation accounts and the profit or loss on such disposition is reflected in income. Depreciation is recorded over the estimated service lives of the related assets using primarily the straight-line method. Amortization of leasehold improvements is calculated by using the straight-line method over the estimated useful life of the asset or lease term, whichever is shorter. Long-Lived and Intangible Assets Long-lived assets are amortized over their useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets in question may not be recoverable. Impairment would be recorded in circumstances where undiscounted cash flows expected to be generated by an asset are less than the carrying value of that asset. Intangible assets consisted of the follows (in thousands): December 31, 2024 June 30, 2024 Carrying Accumulated Net book Carrying Accumulated Net book value amortization value value amortization value Customer relationships $ 9,800 $ (9,492) $ 308 $ 9,800 $ (9,436) $ 364 Trade name 4,048 (911) 3,137 4,048 (810) 3,238 $ 13,848 $ (10,403) $ 3,445 $ 13,848 $ (10,246) $ 3,602 Amortization expense for intangible assets subject to amortization was approximately $79,000 and $84,000 for the three months ended December 31, 2024 and 2023, respectively. Amortization expense for intangible assets subject to amortization was approximately $157,000 and $168,000 for the six months ended December 31, 2024 and 2023, respectively. Amortization expense for each of the next five fiscal years is estimated to be as follows: 2026 - $297,000; 2027 - $283,000; 2028 - $269,000; 2029 - $210,000; and 2030 - $202,000. The weighted average remaining amortization period for intangible assets was 14.4 years and 14.8 years at December 31, 2024 and June 30, 2024, respectively. Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Equipment Revenue Equipment revenue, which includes shipping and handling costs, is primarily generated from the sale of finished products to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which is typically the date of shipment of the related equipment when the product is picked up by the carrier or customer. A provision for product returns, credits and rebates is recorded as a reduction of equipment revenue in the same period the revenue is recognized. The Company provides limited standard warranty for defective products, usually for a period of 24 to 36 months, and accepts returns for such defective products as well as for other limited circumstances. The Company also provides rebates to customers for meeting specified purchasing targets and other coupons or credits in limited circumstances. Reserves are established for the estimated returns, rebates and credits and such variable consideration is measured based on the most likely amount method. The Company analyzes product sales returns and is able to make reasonable and reliable estimates of product returns based on several factors including actual returns and expected return data communicated to the Company by its customers. Service Revenue Service revenue is primarily generated from the sale of monthly cellular communication services to customers. Those sales predominantly contain a single performance obligation and revenue is recognized ratably with the delivery of cellular communication service over the related monthly period, and when ownership, risks and rewards transfer to the customer. The services are billed monthly, and customers have the right to cancel the cellular communication services at any time, however the contract with the customer does not provide for a refund. Cost of Sales Equipment Cost of Sales Equipment cost of sales is primarily comprised of direct materials and supplies consumed in the manufacturing of products, as well as manufacturing labor, depreciation expense and direct and indirect overhead expenses necessary to acquire and convert the purchased materials and supplies into finished products. Service Cost of Sales Service cost of sales includes the cost of operating our network operations center to manage and deliver telecommunication services. Shipping and Handling Sales and Costs The Company records the amount billed to customers for shipping and handling in net sales ($80,000 and $103,000 in the three months ended December 31, 2024 and 2023, respectively, and $170,000 and $186,000 in the six months ended December 31, 2024 and 2023, respectively); and classifies the costs associated with these sales in cost of sales ($353,000 and $389,000 in the three months ended December 31, 2024 and 2023, respectively and $743,000 and $760,000 in the six months ended December 31, 2024 and 2023, respectively). Advertising and Promotional Costs Advertising and promotional costs are included in "Selling, General and Administrative" (“SG&A”) expenses in the consolidated statements of income and are expensed as incurred. Advertising expense for the three months ended December 31, 2024 and 2023 was $916,000 and $696,000, respectively. Advertising expense for the six months ended December 31, 2024 and 2023 was $1,806,000 and $1,457,000, respectively. Research and Development Costs Research and development (“R&D”) costs incurred by the Company are charged to expense as incurred and are included in operating expenses in the consolidated statements of income. Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority. Treasury Stock Treasury stock is accounted for using the cost method and recorded as a reduction to Stockholders’ equity on the Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. To determine the cost of treasury stock that is either sold or re-issued, we use the first in, first out method. When treasury stock is re-issued at a price higher than its cost, the increase is recorded in additional paid-in capital on the Consolidated Balance Sheets. When treasury stock is re-issued at a price lower than its cost, the decrease is recorded in additional paid-in capital to the extent that there are previously recorded increases to offset the decrease. Any decreases in excess of that amount are recorded in retained earnings on the Consolidated Balance Sheets. Net Income per Share Basic net income per common share (Basic EPS) is computed by dividing net income by the weighted average number of common shares outstanding. Diluted net income per common share (Diluted EPS) is computed by dividing net income by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. The following provides a reconciliation of information used in calculating the per share amounts for the three months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income Weighted Average Shares Net Income per Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 10,467 $ 12,610 36,538 36,829 $ 0.29 $ 0.34 Effect of Dilutive Securities: Stock Options — — 238 189 (0.01) — Diluted EPS $ 10,467 $ 12,610 36,776 37,018 $ 0.28 $ 0.34 Options to purchase 120,000 and 67,500 shares of common stock were excluded for the three months ended December 31, 2024 and 2023, respectively, and were not included in the computation of Diluted EPS because their inclusion would be anti-dilutive. These options were still outstanding at the end of the period. The following provides a reconciliation of information used in calculating the per share amounts for the six months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income per Net Income Weighted Average Shares Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 21,652 $ 23,088 36,706 36,743 $ 0.59 $ 0.63 Effect of Dilutive Securities: Stock Options — — 277 219 — (0.01) Diluted EPS $ 21,652 $ 23,088 36,983 36,962 $ 0.59 $ 0.62 Options to purchase 70,000 and 36,250 shares of common stock were excluded for the six months ended December 31, 2024 and 2023, respectively, and were not included in the computation of Diluted EPS because their inclusion would be anti-dilutive. These options were still outstanding at the end of the period. Stock-Based Compensation The Company has established five share incentive programs as discussed in Note 10. Stock-based awards exchanged for services are accounted for under the fair value method. Accordingly, stock-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date. Determining the fair value of share-based awards at the grant date requires assumptions and judgments about expected volatility, among other factors. Stock-based compensation costs of $386,000 and $303,000 were recognized for the three months ended December 31, 2024 and 2023, respectively. Stock-based compensation costs of $757,000 and $610,000 were recognized for the six months ended December 31, 2024 and 2023, respectively. Foreign Currency The Company has determined the functional currency of all foreign subsidiaries is the U.S. Dollar. All foreign operations are considered a direct and integral part or extension of the Company’s operations. The day-to-day operations of all foreign subsidiaries are dependent on the economic environment of the U.S. Dollar. Therefore, no realized and unrealized gains and losses associated with foreign currency translation are recorded for the three and six months ended December 31, 2024 or 2023. Segment Reporting The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture and sales of high-tech security devices and related cellular communication services for the devices. The Company’s Chief Operating Decision Maker, (the President, Chief Operating Officer, and Chief Financial Officer) evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results. The Company has presented required geographical data in Note 14. Leases The Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. If the Company has options to renew or terminate certain leases, those options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less. See Note 13 – Commitments and Contingencies; Leases for additional accounting policies and disclosures. Legal and Other Contingencies The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty. An estimated loss from a loss contingency such as a legal proceeding or claim is accrued by a charge to income if it is probable that an asset has been impaired, or a liability has been incurred and the amount of the loss can be reasonably estimated. In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . The update expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. It further requires disclosure of the amount and description of its composition for other segment items, and interim disclosures of both a reportable segment’s profit or loss and assets. The guidance requires disclosure of the title and position of the chief operating decision maker and how reported measures of segment profit or loss are used to assess performance and allocate resources. This pronouncement is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public entities to disclose consistent categories and greater disaggregation of information in the rate reconciliation and for income taxes paid. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements. The Company is evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Revenue Recognition and Contrac

Revenue Recognition and Contracts with Customers	6 Months Ended
Revenue Recognition and Contracts with Customers	Dec. 31, 2024
Revenue Recognition and Contracts with Customers
Revenue Recognition and Contracts with Customers	NOTE 2 – Revenue Recognition and Contracts with Customers The Company is engaged in the development, manufacture, and distribution of security products, encompassing access control systems, door security products, intrusion and fire alarm systems, alarm communication services, and video surveillance products for commercial and residential use. The Company also provides wireless communication service for intrusion and fire alarm systems on a monthly basis. These products and services are used for commercial, residential, institutional, industrial and governmental applications, and are sold primarily to independent distributors, dealers and installers of security equipment. Sales to unaffiliated customers are primarily shipped from the United States. As of December 31, 2024 and June 30, 2024, the Company included refund liabilities of approximately $4,814,000 and $6,295,000, respectively, in current liabilities. As of December 31, 2024 and June 30, 2024, the Company included return-related assets of approximately $1,263,000 and $1,586,000, respectively, in other current assets. As a percentage of gross sales, returns, rebates and allowances were 4% and 6% for the three months ended December 31, 2024 and 2023, respectively. As a percentage of gross sales, returns, rebates and allowances were 7% and 5% for the six months ended December 31, 2024 and 2023, respectively. The Company disaggregates revenue from contracts with customers into major product lines. The Company determines that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. As noted in the accounting policy footnote, the Company’s business consists of one operating segment. Following is the disaggregation of revenues based on major product lines (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Major Product Lines: Intrusion and access alarm products $ 7,556 $ 11,258 $ 16,619 $ 20,554 Door locking devices 14,169 17,749 28,023 32,844 Services 21,208 18,540 42,294 35,825 Total Revenues $ 42,933 $ 47,547 $ 86,936 $ 89,223

Business and Credit Concentrati

Business and Credit Concentrations	6 Months Ended
Business and Credit Concentrations	Dec. 31, 2024
Business and Credit Concentrations
Business and Credit Concentrations	NOTE 3 – Business and Credit Concentrations An entity is more vulnerable to concentrations of credit risk if it is exposed to risk of loss greater than it would have had if it mitigated its risk through diversification of customers. Such risks of loss manifest themselves differently, depending on the nature of the concentration, and vary in significance. The Company had two customers with an accounts receivable balance that comprised of 11% and 13% as of December 31, 2024. These same two customers had an accounts receivable balance that comprised of 17% and 12% as of June 30, 2024. The Company had one additional customer with an accounts receivable balance that comprised of 13% as of December 31, 2024. Sales to any of these customers did not exceed 10% of net sales during the three or six months ended December 31, 2024 and 2023, respectively.

Fair Value Measurement

Fair Value Measurement	6 Months Ended
Fair Value Measurement	Dec. 31, 2024
Fair Value Measurement
Fair Value Measurement	NOTE 4 – Fair Value Measurement Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy: ● Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and ● Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts. The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 2024 and June 30, 2024, respectively: Level 1 Level 2 Level 3 Total December 31, 2024 Cash equivalents U.S. Treasury Securities 2,525,000 - - 2,525,000 Money market funds 72,095,000 - - 72,095,000 Total 74,620,000 - - 74,620,000 Marketable securities U.S. Treasury Securities 7,528,000 - - 7,528,000 Mutual funds 5,648,000 - - 5,648,000 Total 13,176,000 - - 13,176,000 June 30, 2024 Cash equivalents Certificate of deposits 5,402,000 - - 5,402,000 Money market funds 41,116,000 - - 41,116,000 Total 46,518,000 - - 46,518,000 Short-term investments Certificate of deposits 26,980,000 - - 26,980,000 Total 26,980,000 - - 26,980,000 Marketable securities Mutual funds 5,398,000 - - 5,398,000 Total 5,398,000 - - 5,398,000 The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets, as well as certificates of deposits and time deposits that are classified as Level 1 due to their short-term nature. For the three and six months ending December 31, 2024 and 2023, there were no transfers between Levels 1 and 2 investments and no transfers in or out of Level 3.

Marketable Securities

Marketable Securities	6 Months Ended
Marketable Securities	Dec. 31, 2024
Marketable Securities
Marketable Securities	NOTE 5 – Marketable Securities A summary of the fair value of the Company’s investment in marketable securities as of December 31, 2024 and June 30, 2024 is as follows: December 31, 2024 June 30, 2024 Equity Securities $ 5,648 $ 5,398 Debt Securities (available-for-sale) 7,528 — $ 13,176 $ 5,398 Investments in Equity Securities The disaggregated net gains and losses on the equity securities recognized within the accompanying condensed consolidated statements of income for the three and six months ended December 31, 2024 and 2023, are as follows (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Net gains recognized during the period on equity securities $ 57 $ 75 $ 168 $ 117 Less: Net income (losses) recognized during the period on equity securities sold during the period — — — — Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date (76) 128 81 71 $ (19) $ 203 $ 249 $ 188 The following tables summarize the Company’s investments in equity securities at December 31, 2024 and June 30, 2024, respectively (in thousands): December 31, 2024 June 30, 2024 Unrealized Unrealized Cost Fair Value Gain (Loss) Cost Fair Value Gain (Loss) Mutual Funds $ 5,899 5,648 $ (251) $ 5,857 $ 5,398 $ (459) Investment income is recognized when earned and consists principally of dividend income from fixed income mutual funds. Realized gains and losses on sales of investments are determined on a specific identification basis. Investments in Debt Securities The Company had no investment in debt securities at June 30, 2024. The following tables summarize the Company’s investments in debt securities at December 31, 2024 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. Treasury Securities $ 9,976 $ 53 $ — $ 10,029 Included in Cash and cash equivalents $ 2,501 $ - $ — $ 2,501 Included in Marketable securities $ 7,475 $ 53 $ — $ 7,528 The debt investments all mature within one year or less, and the Company did not recognize any credit or non-credit related losses related to its debt securities during the three and six months ended December 31, 2024.

Inventories

Inventories	6 Months Ended
Inventories	Dec. 31, 2024
Inventories
Inventories	NOTE 6 - Inventories Inventories, net of reserves are valued at lower of cost (first-in, first-out method) or net realizable value. Inventories, net of reserves consist of the following (in thousands): December 31, June 30, 2024 2024 Component parts $ 32,203 $ 32,283 Work-in-process 7,607 7,509 Finished product 9,864 10,121 $ 49,674 $ 49,913 Classification of inventories: Current $ 37,634 $ 34,804 Non-current 12,040 15,109 $ 49,674 $ 49,913 The reserve for excess and slow-moving inventory, which reduces inventory in our consolidated balance sheets were $4,800,000 and $5,026,000 as of December 31, 2024 and June 30, 2024, respectively.

Property, Plant, and Equipment

Property, Plant, and Equipment	6 Months Ended
Property, Plant, and Equipment	Dec. 31, 2024
Property, Plant, and Equipment
Property, Plant, and Equipment	NOTE 7 – Property, Plant, and Equipment Property, plant and equipment consist of the following (in thousands): December 31, 2024 June 30, 2024 Useful Life in Years Land $ 904 $ 904 N/A Buildings 8,911 8,911 30 to 40 Molds and dies 7,548 7,539 3 to 5 Furniture and fixtures 3,702 3,613 5 to 10 Machinery and equipment 30,854 29,761 3 to 10 Building improvements 3,657 3,129 Shorter of the lease term or life of asset 55,576 53,857 Less: accumulated depreciation and amortization (45,661) (44,780) $ 9,915 $ 9,077 Depreciation and amortization expense on property, plant, and equipment was approximately $506,000 and $467,000 for the three months ended December 31, 2024 and 2023, respectively. Depreciation and amortization expense on property, plant, and equipment was approximately $976,000 and $920,000 for the six months ended December 31, 2024 and 2023, respectively.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Dec. 31, 2024
Income Taxes
Income Taxes	NOTE 8 - Income Taxes The provision for income taxes represents Federal, foreign, and state and local income taxes. The effective rate differs from statutory rates due to the effect of state and local income taxes, tax rates in foreign jurisdictions, global intangible low-taxed income (“GILTI”), tax benefit of R&D credits, and certain nondeductible expenses. Our effective tax rate will change from quarter to quarter based on recurring and non-recurring factors including, but not limited to, the geographical mix of earnings, enacted tax legislation, and state and local income taxes. In addition, changes in judgment from the evaluation of new information resulting in the recognition de-recognition or re-measurement of a tax position taken in a prior annual period is recognized separately in the quarter of the change. For the six months ended December 31, 2024 the Company recognized total pre-tax book income of $25,092,000, comprised of $4,306,000 and $20,786,000 of domestic and foreign pre-tax book income, respectively. The Company’s practice is to recognize interest and penalties related to income tax matters in income tax expense and accrued income taxes. As of December 31, 2024, the Company had accrued interest totaling $229,000, as well as $754,000 of unrecognized net tax benefits that, if recognized, would favorably affect the Company’s effective income tax rate in any future period. For the six months ended December 31, 2024, additional tax liability and interest expense were accrued for in the amount of $54,000 and $35,000, respectively. The company has FIN 48 liabilities accrued due to historic Section 956 positions. These positions would not be reversed until the earlier of when the statute of limitation lapses noting that Section 956 adjustments are subject to a 6-year period under the constructive dividend rules, or the position is effectively settled via an IRS audit. Based on the tax returns filed in April of 2019, the six year statute of limitations would expire during Q4 of June 30, 2025. We file a consolidated U.S. income tax return and tax returns in certain state and local and foreign jurisdictions. As of December 31, 2024, fiscal years 2021 and forward are still open for examination, in addition to fiscal year 2018, which is subject to a six year statute of limitations. In addition, the Company has a wholly-owned subsidiary which operates in a Free Zone in the Dominican Republic (“DR”) and is exempt from DR income tax. In December 2022, the Company received a letter from the IRS (“IRS”) notifying it that the IRS has closed its examination of the Company’s income tax return for fiscal year ended June 30, 2020. There has been no changes proposed in relation to this examination.

Long-Term Debt

Long-Term Debt	6 Months Ended
Long-Term Debt	Dec. 31, 2024
Long-Term Debt.
Long-Term Debt	NOTE 9 - Long-Term Debt On February 9, 2024, the Company and its primary bank, HSBC Bank USA National Association (“HSBC”), agreed to amend and restate the existing Third Amended and Restated Credit Agreement (“Agreement”) dated June 29, 2012, as amended, between the Registrant and HSBC with the Fourth Amended and Restated Credit Agreement (“Amended Agreement”). The Amended Agreement extends the term of the Agreement from June 28, 2024, to February 9, 2029. The Amended Agreement also increases the available revolving credit line from $11,000,000 to $20,000,000 and replaces the LIBOR benchmark rate with the Secured Overnight Financing Rate (SOFR) benchmark rate. The Amended Agreement provides for a SOFR-based interest rate option of SOFR During Fiscal 2020, the Company received the proceeds of promissory notes (the "PPP Loan Agreement"), entered into between the Company and HSBC Bank USA N.A., as lender (the "Lender). The Lender made the loans pursuant to the Paycheck Protection Program (the "PPP"), created by Section 1102 of the CARES Act. Pursuant to the PPP Loan Agreement, the Lender made loans to the Company with an aggregate principal amount of $3,904,000 (the "PPP Loan"). The PPP Loan and related extinguishment was accounted for in accordance with ASC 470 “Debt”. Pursuant to the CARES Act, the loans may be forgiven, and during Fiscal 2022, the PPP Loans were forgiven, in their entirety, in accordance with guidelines set forth in the PPP Loan Agreement. In accordance with the CARES Act, the federal government reserves the right to audit any forgiveness of PPP Loan’s for a period of six years from the date of forgiveness, and it has indicated that it intends to audit loans that were in excess of $2 million.

Stock Options

Stock Options	6 Months Ended
Stock Options	Dec. 31, 2024
Stock Options
Stock Options	NOTE 10 - Stock Options The Company follows ASC 718 (“Share-Based Payment”), which requires that all share-based payments to employees, including stock options, be recognized as compensation expense in the consolidated financial statements based on their fair values and over the requisite service period. For the three months ended December 31, 2024 and 2023, the Company recorded non-cash compensation expense of $386,000 ($0.01 per basic and diluted share) and $335,000 ($0.01 per basic and diluted share), respectively, relating to stock-based compensation which are included in SG&A in the consolidated statements of income. For the six months ended December 31, 2024 and 2023, the Company recorded non-cash compensation expense of $757,000 ($0.02 per basic and diluted share) and $610,000 ($0.01 per basic and diluted share), respectively, relating to stock-based compensation which are included in SG&A in the consolidated statements of income. 2012 Employee Stock Option Plan In December 2012, the stockholders approved the 2012 Employee Stock Option Plan (the 2012 Employee Plan). The 2012 Employee Plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 1,900,000 shares of the Company’s common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options, which are intended to qualify as incentive stock options (“ISOs”) or non-incentive stock options, to employees. Any plan participant who is granted ISOs and possesses more than 10% of the voting rights of the Company’s outstanding common stock must be granted an option with a price of at least 110% of the fair market value on the date of grant and a term of 10 years. Under the 2012 Employee Plan, stock options may be granted to employees with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable, in whole or in part, at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2024, 361,036 stock options were outstanding, 265,660 stock options were exercisable and no further stock options were available for grant under this plan after December 2022. The following table reflects activity under the 2012 Employee Plan for the six months ended December 31: 2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 363,036 $ 21.47 521,580 $ 19.37 Forfeited/Lapsed — — (11,000) $ 3.15 Exercised (2,000) $ 26.94 (31,600) $ 22.13 Outstanding, end of period 361,036 $ 21.44 478,980 $ 19.56 Exercisable, end of period 265,660 $ 21.36 289,728 $ 18.58 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised $ 35,000 $ 375,000 Total intrinsic value of options outstanding $ 5,100,000 $ 7,034,000 Total intrinsic value of options exercisable $ 3,772,000 $ 4,539,000 A total of 2,000 stock options were exercised during both the six months ended December 31, 2024. There were no stock options exercised during the three months ended December 31, 2024. $54,000 cash was received from the option exercises during the six months ended December 31, 2024. The actual tax benefit realized for the tax deductions from option exercises during both the three and six months ended December 31, 2024 was $0. A total of 31,600 stock options were exercised during both the three and six months ended December 31, 2023. The 31,600 options that were exercised during the three and six months ended December 31, 2023 were settled by the Company withholding 20,567 from the shares issuable on exercise of the options. The withheld shares of common stock had an aggregate fair market value on the date of exercise equal to the purchase price being paid. No cash was received from the option exercises during both the three and six months ended December 31, 2023. The following table summarizes information about stock options outstanding under the 2012 Employee Plan at December 31, 2024: Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $10.02 ‑ $26.94 361,036 6.65 $ 21.44 265,660 $ 21.36 361,036 6.65 $ 21.44 265,660 $ 21.36 As of December 31, 2024, there was $677,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2012 Employee Plan. 67,600 and 76,700 options vested during the three and six months ended December 31, 2024. The total grant date fair value of the options vesting during the three and six months ended December 31, 2024 was $670,000 and $782,000, respectively. 74,000 and 84,700 options vested during the three and six months ended December 31, 2023. The total grant date fair value of the options vesting during the three and six months ended December 31, 2023 was $724,000 and $849,000 , respectively. 2012 Non-Employee Stock Option Plan In December 2012, the stockholders approved the 2012 Non-Employee Stock Option Plan (the 2012 Non-Employee Plan). This plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 100,000 shares of the Company’s common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options to non-employee directors and consultants to the Company and its subsidiaries. Under the 2012 Non-Employee Plan, stock options may be granted with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable in whole or in part at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2024, 20,400 stock options were outstanding, 18,480 stock options were exercisable and no further stock options were available for grant under this plan after December 2022. The following table reflects activity under the 2012 Non-Employee Plan for the six months ended December 31: 2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 20,400 $ 14.39 20,400 $ 14.39 Forfeited/Lapsed — — — — Exercised — — — — Outstanding, end of period 20,400 $ 14.39 20,400 $ 14.39 Exercisable, end of period 18,480 $ 13.50 15,840 $ 12.44 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised n/a n/a Total intrinsic value of options outstanding $ 432,000 $ 405,000 Total intrinsic value of options exercisable $ 408,000 $ 345,000 No stock options were exercised during the three and six months ended December 31, 2024 and 2023, respectively. No cash was received from option exercises during the three and six months ended December 31, 2024 and 2023, respectively, and the actual tax benefit realized for the tax deductions from option exercises was $0 for both periods. The following table summarizes information about stock options outstanding under the 2012 Non-Employee Plan at December 31, 2024: Options outstanding Options exercisable Weighted average Weighted Weighted Number remaining average exercise Number average exercise Range of exercise prices outstanding contractual life price exercisable price $4.35 - $22.93 20,400 5.14 $ 14.39 18,480 $ 13.50 20,400 5.14 $ 14.39 18,480 $ 13.50 As of December 31, 2024, there was $15,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2012 Non-Employee Plan. 1,920 options vested during both the three and six months ended December 31, 2024 and 2023, respectively. The total grant date fair value of the options vesting during both the three and six months ended December 31, 2024 and 2023 was $19,000. 2018 Non-Employee Stock Option Plan In December 2018, the stockholders approved the 2018 Non-Employee Stock Option Plan (the “2018 Non-Employee Plan”). This plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 100,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options to non-employee directors and consultants to the Company and its subsidiaries. Under the 2018 Non-Employee Plan, stock options may be granted with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable in whole or in part at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2024, 64,900 stock options were outstanding, 62,200 stock options were exercisable and 4,000 further stock options were available for grant under this plan. There were no options granted during the six months ended December 31, 2024 and 2023. No options may be granted under this plan after December 2028. The following table reflects activity under the 2018 Non-Employee Plan for the six months ended December 31: 2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 68,900 $ 14.54 75,000 $ 14.83 Granted — — — — Forfeited/Lapsed (4,000) $ 22.93 — — Exercised — (1,600) $ 15.27 Outstanding, end of period 64,900 $ 14.02 73,400 $ 14.82 Exercisable, end of period 62,200 $ 13.63 58,620 $ 13.81 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised n/a $ 28,000 Total intrinsic value of options outstanding $ 1,398,000 $ 1,426,000 Total intrinsic value of options exercisable $ 1,364,000 $ 1,198,000 No stock options were exercised during both the three and six months ended December 31, 2024. No cash was received from option exercises during both the three and six months ended December 31, 2024, and the actual tax benefit realized for the tax deductions from option exercises was $0. A total of 1,600 stock options were exercised during the three and six months ended December 31, 2023. The 1,600 options that were exercised during the three and six months ended December 31, 2023 were settled by the Company withholding 740 from the shares issuable on exercise of the options. The withheld shares of Common Stock had an aggregate fair market value on the date of exercise equal to the purchase price being paid. No cash was received from the option exercises during the three and six months ended December 31, 2023. The actual tax benefit realized for the tax deductions from option exercises during the three and six months ended December 31, 2023 was $6,000 each period. The following table summarizes information about stock options outstanding under the 2018 Non-Employee Plan at December 31, 2024: Options outstanding Options exercisable Weighted average Weighted Weighted Number remaining average exercise Number average exercise Range of exercise prices outstanding contractual life price exercisable price $8.10 - $22.93 64,900 5.10 $ 14.02 62,200 $ 13.63 64,900 5.10 $ 14.02 62,200 $ 13.63 As of December 31, 2024, there was $20,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2018 Non-Employee Plan. 2,700 options vested during both the three and six months ended December 31, 2024. The total grant date fair value of the options vesting during both the three and six months ended December 31, 2024 was $27,000. 9,500 options vested during both the three and six months ended December 31, 2023, respectively. The total grant date fair value of the options vesting during both the three and six months ended December 31, 2023 under this plan was $89,000 for both periods. 2020 Non-Employee Stock Option Plan In May 2020, the stockholders approved the 2020 Non-Employee Stock Option Plan (the “2020 Non-Employee Plan”). This plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 100,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options to non-employee directors and consultants to the Company and its subsidiaries. Under the 2020 Non-Employee Plan, stock options may be granted with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable in whole or in part at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2024, 51,900 stock options were outstanding, 37,520 stock options were exercisable and 45,100 stock options were available for grant under this plan. No options were granted during the six months ended December 31, 2024 and 2023, respectively. No options may be granted under this plan after May 2030. The following table reflects activity under the 2020 Non-Employee Plan for the six months ended December 31: 2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 56,900 $ 23.35 56,900 $ 23.35 Granted — — — — Forfeited/Lapsed (2,000) $ 26.94 — — Exercised (3,000) $ 26.94 — — Outstanding, end of period 51,900 $ 23.00 56,900 $ 23.35 Exercisable, end of period 37,520 $ 21.55 29,140 $ 21.41 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised $ 32,000 n/a Total intrinsic value of options outstanding $ 652,000 $ 620,000 Total intrinsic value of options exercisable $ 525,000 $ 374,000 A total of 0 and 3,000 stock options were exercised during the three and six months ended December 31, 2024, respectively. 3,000 stock options exercised during the six months ended December 31, 2024 were settled by the company withholding 2,151 shares from the shares issuable on exercise of the options. The withheld shares of common stock had an aggregate fair market value on the date of exercise equal to the purchase price being paid. The actual tax benefit realized for the tax deductions from option exercises during the three and six months ended December 31, 2024 was $0 and $7,000, respectively. No stock options were exercised during both the three and six months ended December 31, 2023. No cash was received from option exercises during either of the three and six months ended December 31, 2023 and the actual tax benefit realized for the tax deductions from option exercises was $0 for both periods. The following table summarizes information about stock options outstanding under the 2020 Non-Employee Plan at December 31, 2024: Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $11.40 - $30.71 51,900 7.03 $ 23.00 37,520 $ 21.55 51,900 7.03 $ 23.00 37,520 $ 21.55 As of December 31, 2024, there was $137,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2020 Non-Employee Plan. 3,380 and 10,380 options vested during both of the three and six months ended December 31, 2024 and 2023, respectively. The total grant date fair value of the options vesting during both the three and six months ended December 31, 2024 and 2023 was $34,000 and $113,000, respectively. 2022 Employee Stock Option Plan In December 2022, the stockholders approved the 2022 Employee Stock Option Plan (the “2022 Employee Plan”). The plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 950,000 shares of the Company’s common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options, which are intended to qualify as incentive stock options (“ISOs”) or non-incentive stock options, to valued employees. Any plan participant who is granted ISOs and possesses more than 10% of the voting rights of the Company’s outstanding common stock must be granted an option with a price of at least 110% of the fair market value on the date of grant. Under the 2022 Employee Plan, stock options may be granted to valued employees with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable, in whole or in part, at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2024, 130,000 stock options were outstanding, 28,000 stock options were exercisable and 820,000 stock options were available for grant under this plan. No stock options were granted during the six months ended December 31, 2024. There were 10,000 options granted during the three and six months ended December 31, 2023. No options may be granted under this plan after December 2032. The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2024 2023 Risk-free interest rates n/a 4.66 % Expected lives n/a 5.76 Years Expected volatility n/a 48.71 % Expected dividend yields n/a 1.48 % The following table reflects activity under the 2022 Employee Plan for the six months ended December 31: 2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 130,000 $ 41.38 5,000 $ 40.01 Granted — — 10,000 $ 21.60 Forfeited/Lapsed — — (5,000) $ 40.01 Exercised — — — — Outstanding, end of period 130,000 $ 41.38 10,000 $ 21.60 Exercisable, end of period 28,000 $ 39.96 2,000 $ 21.60 Weighted average fair value at grant date of options granted n/a $ 9.75 Total intrinsic value of options exercised n/a n/a Total intrinsic value of options outstanding $ 140,000 $ 127,000 Total intrinsic value of options exercisable $ 56,000 $ 25,300 No options were exercised during both the three and six months ended December 31, 2024 and 2023, respectively. No cash was received from option exercises during both the three and six months ended December 31, 2024 and 2023 and the actual tax benefit realized for the tax deductions from option exercises was $0. The following table summarizes information about stock options outstanding under the 2022 Employee Plan at December 31, 2024: Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $21.60 - $49.39 130,000 9.30 $ 41.38 28,000 $ 39.96 130,000 9.30 $ 41.38 28,000 $ 39.96 As of December 31, 2024, there was $1,816,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2022 Employee Plan. 2,000 options vested during both the three and six months ended December 31, 2024 and 2023, respectively. The total grant date fair value of the options vesting during both the three and six months ended December 31, 2024 and 2023 under this plan was $19,500 , respectively.

Stockholders' Equity Transactio

Stockholders' Equity Transactions	6 Months Ended
Stockholders' Equity Transactions	Dec. 31, 2024
Stockholders' Equity Transactions
Stockholders' Equity Transactions	NOTE 11 – Stockholders’ Equity Transactions The following tables summarizes information about dividends declared by the Company for the six months ended December 31, 2024 and the fiscal year ended June 30, 2024: Dividend Declaration Date Stockholders of Record Date Dividend Payable Date Per Share Cash Dividend Amount November 1, 2024 December 12, 2024 January 3, 2025 $0.125 August 22, 2024 September 12, 2024 October 3, 2024 $0.125 May 2, 2024 June 3, 2024 June 24, 2024 $ 0.10 February 1, 2024 March 1, 2024 March 22, 2024 $ 0.10 November 2, 2023 December 1, 2023 December 22, 2023 $ 0.08 August 18, 2023 September 1, 2023 September 22, 2023 $ 0.08 On September 16, 2014 the Company’s board of directors authorized the repurchase of up to 2 million of the approximately 38.8 million shares of the Company’s common stock then outstanding. Such repurchases may be made from time to time in the open market or in privately negotiated transactions subject to market conditions and the market price of the common stock. In December of Fiscal 2018, the board of directors authorized the repurchase of up to an additional 1 million shares. In November of Fiscal 2025, the board authorized the repurchase of up to an additional 1 million shares. During the first quarter of the fiscal year ended June 30, 2025, the Company repurchased 193,252 shares of its outstanding common stock at a weighted average price of $37.67. During the second quarter of the fiscal year ended June 30, 2025, the Company repurchased 282,647 shares of its outstanding common stock at a weighted average price of $37.95. Shares repurchased through the six months ended December 31, 2024, are included in the Company’s Treasury Stock as of December 31, 2024. The Company currently has available 1,104,741 shares that can be repurchased under this authorization. The following tables summarizes information about shares repurchased by the Company for the six months ended December 31, 2024: Total Number of Maximum Total Shares Purchased as Number of Shares Number of Average Part of Publicly that May Yet Be Shares Price Paid Announced Plans or Purchased Under Period Purchased per Share Programs Plans or Programs September 10, 2024 - September 19, 2024 193,252 $ 37.67 193,252 1,104,741 November 7, 2024 - December 19, 2024 282,647 $ 37.95 282,647 1,104,741 Total for the 6 months ended December 31, 2024 475,899 $ 37.84 475,899 1,104,741 During the six months ended December 31, 2024, certain employees and directors exercised stock options under the Company's 2012 Employee and 2020 Non-Employee Stock Option Plans totaling 5,000 shares. Of the 5,000 shares exercised, 3,000 of these exercises were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange for shares of the Company's common stock that are owned by the optionees. The number of shares withheld by the Company was 2,151 and was based upon the aggregate fair market value on the date of exercise equal to the purchase price being paid. There were no stock option exercises from certain employees and directors during the three months ended December 31, 2024.

401(k) Plan

401(k) Plan	6 Months Ended
401(k) Plan	Dec. 31, 2024
401(k) Plan
401(k) Plan	NOTE 12 - 401(k) Plan The Company maintains a 401(k) plan (“the Plan”) that covers all U.S. employees and is qualified under Sections 401(a) and 401(k) of the Internal Revenue Code. Company contributions to this plan are discretionary and totaled $69,000 and $58,000 for the three months ended December 31, 2024 and 2023, respectively. Company contributions to this plan are discretionary and totaled $138,000 and $119,000 for the six months ended December 31, 2024 and 2023, respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Dec. 31, 2024
Commitments and Contingencies.
Commitments and Contingencies	NOTE 13 - Commitments and Contingencies Leases Our lease obligation consists of a 99-year lease, entered into by one of the Company’s foreign subsidiaries, for approximately four acres of land in the Dominican Republic on which the Company’s principal production facility is located. The lease, which commenced on April 26, 1993 and expires in 2092, initially had an annual base rent of approximately $235,000 plus $53,000 in annual service charges. On September 14, 2022, a lease modification was executed which provides for an annual base rent of $235,000 plus $105,000 in annual service charges. The service charges increase 2% annually over the remaining life of the lease. The modification resulted in a remeasurement of the operating lease asset and liability and the effect was a reduction to the asset and liability of $1.3 million. Operating leases are included in operating lease right-of-use assets, accrued expenses and operating lease liabilities, non-current on our condensed consolidated balance sheets. For the three months ended December 31, 2024 and 2023 cash payments against operating lease liabilities totaled $115,000 and $86,000, respectively. For the six months ended December 31, 2024 and 2023 cash payments against operating lease liabilities totaled $172,000 and $171,000, respectively. Supplemental balance sheet information related to operating leases was as follows: Weighted-average remaining lease term 67 Years Weighted-average discount rate 6.25 % The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2024 (in thousands): Year Ending June 30, Amount 2025 $ 172 2026 346 2027 349 2028 351 2029 353 Thereafter 29,665 Total future minimum lease payments $ 31,236 Less: Imputed interest 25,901 Total $ 5,335 Operating lease expense totaled approximately $144,000 and $129,000 for the three months ended December 31, 2024 and 2023, respectively. Operating lease expense totaled approximately $239,000 and $253,000 for the six months ended December 31, 2024 and 2023, respectively. Litigation On August 29, 2023, a purported class action, brought on behalf of a putative class who acquired publicly traded NAPCO securities between November 7, 2022 and August 18, 2023, was filed in the United States District Court for the Eastern District of New York against the Company, its Chairman and Chief Executive Officer, and its Chief Financial Officer. The action, captioned Zornberg v. NAPCO Security Technologies, Inc. et al., asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in connection with statements made in the Company’s quarterly reports and earnings releases during the period of November 7, 2022 through May 8, 2023. A lead plaintiff was appointed in November 2023 and lead plaintiff filed an Amended Complaint on February 16, 2024. The Amended Complaint added claims under Sections 11, 12, and 15 of the Securities Act of 1933 in connection with the secondary public offering in February 2023. These additional claims are brought against the defendants named in the initial complaint, as well as the directors who allegedly signed the offering materials (prospectuses and registration statement in connection with the offering), and the underwriters for the offering. The Company filed a motion to dismiss the Amended Complaint on April 26, 2024. The Company intends to vigorously defend against the action. On November 26, 2024, a putative derivative lawsuit captioned Minzer v. Soloway, et al., Case No. 2024-1218, was filed in the Court of Chancery in the State of Delaware against the Company’s Chairman and Chief Executive Officer, Chief Financial Officer, and certain current and former directors. The Company is a “Nominal Defendant” in the lawsuit. The complaint alleges, among other things, that the defendants breached their fiduciary duties and aided and abetted breach of fiduciary duties by allowing the Company to remain with ineffective internal controls over financial reporting and inventory and by allowing for the dissemination of false and misleading financial information in public filings. The complaint also brings breach of fiduciary duty and unjust enrichment claims in connection with stock sales by the Company’s Chairman and Chief Executive Officer and its Chief Financial Officer and seeks indemnity and contribution. The Company’s status as a “Nominal Defendant” in the action reflects the fact that the lawsuit is maintained by the named plaintiff on behalf of the Company and that the plaintiff seeks damages on the Company’s behalf. Defendants’ motion to dismiss and/or stay the case is due on February 28, 2025. With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. As of the end of the period covered by this report, the Company has not recorded a liability for the matter disclosed in this note. It is possible that the Company could be required to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report. Employment Agreements The Company is obligated under three employment agreements and one severance agreement with executive officers of the Company. The employment agreements are with the Company’s CEO, Senior Vice President of Finance and Chief Accounting Officer (“SVP of Finance”) and the Senior Vice President of Engineering and Chief Technology Officer (“the SVP of Engineering”) and the severance agreement is with the Company’s President, Chief Operating Officer and Chief Financial Officer (“CFO”). The employment agreement with the CEO provides for an annual salary of $971,000, as adjusted for inflation; incentive compensation as may be approved by the Board of Directors from time to time and a termination payment in an amount up to 299% of the average of the prior five calendar year’s compensation, subject to certain limitations, as defined in the agreement. The employment agreement renews annually in August unless either party gives the other notice of non-renewal at least six months prior to the end of the applicable term. The employment agreement with the SVP of Finance expires in June 2025 and provides for an annual salary of $350,000. Upon the anniversary date, if terminated by the Company without cause, the SVP of Finance is entitled to severance of six months’ salary and continued company-sponsored health insurance for six months from the date of termination. The employment agreement with the SVP of Engineering expires in August 2026 and provides for an annual salary of $458,000, and, if terminated by the Company without cause, severance of nine month’s salary and continued company-sponsored health insurance for six months from the date of termination. The severance agreement is with the President and CFO and provides for, if terminated by the Company without cause or within three months of a change in corporate control of the Company, severance of nine month’s salary, continued company-sponsored health insurance for six months from the date of termination and certain non-compete and other restrictive provisions.

Geographical Data

Geographical Data	6 Months Ended
Geographical Data	Dec. 31, 2024
Geographical Data
Geographical Data	NOTE 14 – Geographical Data The Company is engaged in one major line of business: the development, manufacture, and distribution of security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products for commercial and residential use. The Company also provides wireless communication service for intrusion and fire alarm systems. These products are used for commercial, residential, institutional, industrial and governmental applications, and are sold worldwide principally to independent distributors, dealers and installers of security equipment. Sales to unaffiliated customers are primarily shipped from the United States. The Company has customers worldwide with major concentrations in North America. Financial Information Relating to Domestic and Foreign Operations (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Sales to external customers (1) Domestic $ 42,679 $ 47,291 $ 86,367 $ 88,661 Foreign 254 256 569 562 Total Net Sales $ 42,933 $ 47,547 $ 86,936 $ 89,223 December 31, 2024 June 30, 2024 Identifiable assets: United States $ 160,536 $ 164,365 Dominican Republic (2) 42,148 43,387 Total Identifiable Assets $ 202,684 $ 207,752 (1) All of the Company’s sales originate in the United States and are shipped primarily from the Company’s facilities in the United States. There were no sales into any one foreign country in excess of 10% of total Net Sales. (2) Consists primarily of inventories (December 31, 2024 = $31,864 ; June 30, 2024 = $33,584 ), operating lease right of use (December 31, 2024 = $5,335 ; June 30, 2024 = $5,487 ) and fixed assets (December 31, 2024 = $4,312 ; June 30, 2024 = $3,623 ) located at the Company’s principal manufacturing facility in the Dominican Republic.

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Dec. 31, 2024
Subsequent Events
Subsequent Events	NOTE 15 - Subsequent Events The Company has evaluated subsequent events occurring after the end of the period covered by the condensed consolidated financial statements for events requiring recording or disclosure in the condensed consolidated financial statements. On January 30, 2025, the Company’s Board of Directors declared a cash dividend of $.125 per share payable on April 3, 2025 to stockholders of record on March 12, 2025.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 10,467	$ 11,185	$ 12,610	$ 10,478	$ 21,652	$ 23,088

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Nature of Business and Summar_2

Nature of Business and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2024
Nature of Business and Summary of Significant Accounting Policies
Nature of Business	Nature of Business : Napco Security Technologies, Inc (“NAPCO”, “the Company”, “we”, “our”) is one of the leading manufacturers and designers of high-tech electronic security devices, cellular communication services for intrusion and fire alarm systems as well as a leading provider of school safety solutions. We offer a diversified array of security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. These products are used for commercial, residential, institutional, industrial and governmental applications, and are sold worldwide principally to independent distributors, dealers and installers of security equipment. We have experienced significant growth in recent years, primarily driven by our recurring service revenues generated from wireless communication services for intrusion and fire alarm systems, as well as our school security products that are designed to meet the increasing needs to enhance school security as a result of on-campus shooting and violence in the U.S.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Napco Security Technologies, Inc. and its wholly-owned subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.
Accounting Estimates	Accounting Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We continuously evaluate our estimates and judgments based on historical experience, as well as other factors that we believe to be reasonable under the circumstances. The results of our evaluation form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Critical estimates include management’s judgments associated with reserves for sales returns and allowances, allowance for credit losses, overhead expenses applied to inventory, inventory reserves, valuation of intangible assets, share based compensation and income taxes. These estimates may change in the future if underlying assumptions or factors change, and actual results may differ from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The methods and assumptions used to estimate the fair value of the following classes of financial instruments were: Current Assets and Current Liabilities - The carrying amount of cash and cash equivalents, certificates of deposits, marketable securities, current receivables and payables and certain other short-term financial instruments approximate their fair value as of December 31, 2024 and June 30, 2024 due to their short-term maturities.
Cash and Cash Equivalents and Investments - other	Cash and Cash Equivalents and Investments – other All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit, U.S. treasury securities and time deposit accounts. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. Cash and cash equivalents include approximately $74,620,000 of short-term time deposits, consisting of money market funds totaling $72,095,000 and $2,525,000 of U.S. treasury securities as of December 31, 2024. Cash and cash equivalents include approximately $46,518,000 of short-term time deposits, consisting of certificates of deposit totaling $5,402,000 and $41,116,000 in a money market fund as of June 30, 2024. The Company classifies these highly liquid investments with original maturities of three months or less as cash equivalents. Certificates of deposit with an original maturity greater than three months are classified as Investments-other. Cash and cash equivalents consist of the following as of (in thousands): December 31, 2024 June 30, 2024 Cash $ 11,399 $ 18,823 Money Market Fund 72,095 41,116 U.S. Treasury Securities 2,525 — Certificate of Deposits — 5,402 $ 86,019 $ 65,341 Investments-other consists of the following as of (in thousands): December 31, 2024 June 30, 2024 Certificate of Deposits $ — $ 26,980 $ — $ 26,980 Certificates of deposit are recorded at the original cost plus accrued interest. There were no certificate of deposits outstanding at December 31, 2024. The Company’s certificates of deposits as of June 30, 2024 consist of the following (in thousands): June 30, 2024 Balance Sheet Classification Interest Rate Maturity Date Cost Carrying Value Cash and Cash Equivalents 4.70% 8/22/2024 $ 5,374 $ 5,402 Investments - other 4.55% - 4.75% 7/25/2024 - 10/24/2024 26,709 26,980 The Company has cash balances in banks in excess of the maximum amount insured by the FDIC and other international agencies as of December 31, 2024 and June 30, 2024. The Company has not historically experienced any credit losses with balances in excess of FDIC limits.
Marketable Securities	Marketable Securities Investments in debt securities are classified as available-for-sale and realized gains and losses are recorded using the specific identification method. Changes in fair value, excluding credit losses and impairments, are recorded in other comprehensive income. Fair value is calculated based on publicly available market information or other estimates determined by management. If the cost of an investment exceeds its fair value, the Company evaluates, among other factors, general market conditions, credit quality of debt instrument issuers, and the extent to which the fair value is less than cost. To determine credit losses, a systematic methodology is employed that considers available quantitative and qualitative evidence. In addition, specific adverse conditions are considered related to the financial health of, and business outlook for, the investee. If the Company plans to sell the security or it is more likely than not that the Company will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in other income (expense), net and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments. Investments in equity securities with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). The Company performs a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expense), net.
Accounts Receivable	Accounts Receivable Accounts receivable is stated net of the reserves for credit losses of $20,000 and $32,000 as of December 31, 2024 and June 30, 2024, respectively. In accordance with ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326), the Company recognizes an allowance for credit losses for trade receivables to present the net amount expected to be collected as of the balance sheet date. Such allowance is based on the credit losses expected to arise over the life of the asset which includes consideration of past events and historical loss experience, current events and also future events based on our expectation as of the balance sheet date. Receivables are written off when the Company determined that such receivables are deemed uncollectible. The Company pools its receivables based on similar risk characteristics in estimating its expected credit losses. In situations where a receivable does not share the same risk characteristics with other receivables, the Company measures those receivables individually. The Company also continuously evaluates such pooling decisions and adjusts as needed from period to period as risk characteristics change. The Company utilizes the loss rate method in determining its lifetime expected credit losses on its receivables. This method is used for calculating an estimate of losses based primarily on the Company’s historical loss experience. In determining its loss rates, the Company evaluates information related to its historical losses, adjusted for current conditions and further adjusted for the period of time that can be reasonably forecasted. Qualitative and quantitative adjustments related to current conditions and the reasonable and supportable forecast period consider all the following: past due receivables, the customer creditworthiness, changes in the terms of receivables, effect of other external forces such as competition, and legal and regulatory requirements on the level of estimated credit losses in the existing receivables.
Inventories	Inventories Inventories are valued at the lower of cost or net realizable value, with cost being determined on the first-in, first-out (FIFO) method. The reported net value of inventory includes finished saleable products, work-in-process and raw materials that will be sold or used in future periods. Inventory costs include raw materials, direct labor and overhead. The Company’s overhead expenses are applied based, in part, upon estimates of the proportion of those expenses that are related to procuring and storing raw materials as compared to the manufacture and assembly of finished products. These proportions, the method of their application, and the resulting overhead included in ending inventory, are based in part on subjective estimates and actual results could differ from those estimates. The Company records a reserve for excess and slow-moving inventory, which represents any excess of the cost of the inventory over its estimated realizable value. This reserve is calculated using an estimated excess and slow-moving percentage applied to the inventory based on age, historical trends, product life cycle, requirements to support forecasted sales, and the ability to find alternate applications of its raw materials and to convert finished product into alternate versions of the same product to better match customer demand. In addition, and as necessary, the Company may establish specific reserves for future known or anticipated events. There is inherent professional judgment and subjectivity made by both production and engineering members of management in determining the estimated excess and slow-moving percentage (See Note 6). The Company also regularly reviews the period over which its inventories will be converted to sales. Any inventories expected to convert to sales beyond 12 months from the balance sheet date are classified as non-current.
Property, Plant, and Equipment	Property, Plant, and Equipment Property, plant, and equipment are carried at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred; costs of major renewals and improvements are capitalized. At the time property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and accumulated depreciation accounts and the profit or loss on such disposition is reflected in income. Depreciation is recorded over the estimated service lives of the related assets using primarily the straight-line method. Amortization of leasehold improvements is calculated by using the straight-line method over the estimated useful life of the asset or lease term, whichever is shorter.
Long-Lived and Intangible Assets	Long-Lived and Intangible Assets Long-lived assets are amortized over their useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets in question may not be recoverable. Impairment would be recorded in circumstances where undiscounted cash flows expected to be generated by an asset are less than the carrying value of that asset. Intangible assets consisted of the follows (in thousands): December 31, 2024 June 30, 2024 Carrying Accumulated Net book Carrying Accumulated Net book value amortization value value amortization value Customer relationships $ 9,800 $ (9,492) $ 308 $ 9,800 $ (9,436) $ 364 Trade name 4,048 (911) 3,137 4,048 (810) 3,238 $ 13,848 $ (10,403) $ 3,445 $ 13,848 $ (10,246) $ 3,602 Amortization expense for intangible assets subject to amortization was approximately $79,000 and $84,000 for the three months ended December 31, 2024 and 2023, respectively. Amortization expense for intangible assets subject to amortization was approximately $157,000 and $168,000 for the six months ended December 31, 2024 and 2023, respectively. Amortization expense for each of the next five fiscal years is estimated to be as follows: 2026 - $297,000; 2027 - $283,000; 2028 - $269,000; 2029 - $210,000; and 2030 - $202,000. The weighted average remaining amortization period for intangible assets was 14.4 years and 14.8 years at December 31, 2024 and June 30, 2024, respectively.
Revenue Recognition	Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Equipment Revenue Equipment revenue, which includes shipping and handling costs, is primarily generated from the sale of finished products to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which is typically the date of shipment of the related equipment when the product is picked up by the carrier or customer. A provision for product returns, credits and rebates is recorded as a reduction of equipment revenue in the same period the revenue is recognized. The Company provides limited standard warranty for defective products, usually for a period of 24 to 36 months, and accepts returns for such defective products as well as for other limited circumstances. The Company also provides rebates to customers for meeting specified purchasing targets and other coupons or credits in limited circumstances. Reserves are established for the estimated returns, rebates and credits and such variable consideration is measured based on the most likely amount method. The Company analyzes product sales returns and is able to make reasonable and reliable estimates of product returns based on several factors including actual returns and expected return data communicated to the Company by its customers. Service Revenue Service revenue is primarily generated from the sale of monthly cellular communication services to customers. Those sales predominantly contain a single performance obligation and revenue is recognized ratably with the delivery of cellular communication service over the related monthly period, and when ownership, risks and rewards transfer to the customer. The services are billed monthly, and customers have the right to cancel the cellular communication services at any time, however the contract with the customer does not provide for a refund.
Cost of Sales	Cost of Sales Equipment Cost of Sales Equipment cost of sales is primarily comprised of direct materials and supplies consumed in the manufacturing of products, as well as manufacturing labor, depreciation expense and direct and indirect overhead expenses necessary to acquire and convert the purchased materials and supplies into finished products. Service Cost of Sales Service cost of sales includes the cost of operating our network operations center to manage and deliver telecommunication services.
Shipping and Handling Sales and Costs	Shipping and Handling Sales and Costs The Company records the amount billed to customers for shipping and handling in net sales ($80,000 and $103,000 in the three months ended December 31, 2024 and 2023, respectively, and $170,000 and $186,000 in the six months ended December 31, 2024 and 2023, respectively); and classifies the costs associated with these sales in cost of sales ($353,000 and $389,000 in the three months ended December 31, 2024 and 2023, respectively and $743,000 and $760,000 in the six months ended December 31, 2024 and 2023, respectively).
Advertising and Promotional Costs	Advertising and Promotional Costs Advertising and promotional costs are included in "Selling, General and Administrative" (“SG&A”) expenses in the consolidated statements of income and are expensed as incurred. Advertising expense for the three months ended December 31, 2024 and 2023 was $916,000 and $696,000, respectively. Advertising expense for the six months ended December 31, 2024 and 2023 was $1,806,000 and $1,457,000, respectively.
Research and Development Costs	Research and Development Costs Research and development (“R&D”) costs incurred by the Company are charged to expense as incurred and are included in operating expenses in the consolidated statements of income.
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.
Treasury Stock	Treasury Stock Treasury stock is accounted for using the cost method and recorded as a reduction to Stockholders’ equity on the Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. To determine the cost of treasury stock that is either sold or re-issued, we use the first in, first out method. When treasury stock is re-issued at a price higher than its cost, the increase is recorded in additional paid-in capital on the Consolidated Balance Sheets. When treasury stock is re-issued at a price lower than its cost, the decrease is recorded in additional paid-in capital to the extent that there are previously recorded increases to offset the decrease. Any decreases in excess of that amount are recorded in retained earnings on the Consolidated Balance Sheets.
Net Income per Share	Net Income per Share Basic net income per common share (Basic EPS) is computed by dividing net income by the weighted average number of common shares outstanding. Diluted net income per common share (Diluted EPS) is computed by dividing net income by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. The following provides a reconciliation of information used in calculating the per share amounts for the three months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income Weighted Average Shares Net Income per Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 10,467 $ 12,610 36,538 36,829 $ 0.29 $ 0.34 Effect of Dilutive Securities: Stock Options — — 238 189 (0.01) — Diluted EPS $ 10,467 $ 12,610 36,776 37,018 $ 0.28 $ 0.34 Options to purchase 120,000 and 67,500 shares of common stock were excluded for the three months ended December 31, 2024 and 2023, respectively, and were not included in the computation of Diluted EPS because their inclusion would be anti-dilutive. These options were still outstanding at the end of the period. The following provides a reconciliation of information used in calculating the per share amounts for the six months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income per Net Income Weighted Average Shares Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 21,652 $ 23,088 36,706 36,743 $ 0.59 $ 0.63 Effect of Dilutive Securities: Stock Options — — 277 219 — (0.01) Diluted EPS $ 21,652 $ 23,088 36,983 36,962 $ 0.59 $ 0.62 Options to purchase 70,000 and 36,250 shares of common stock were excluded for the six months ended December 31, 2024 and 2023, respectively, and were not included in the computation of Diluted EPS because their inclusion would be anti-dilutive. These options were still outstanding at the end of the period.
Stock-Based Compensation	Stock-Based Compensation The Company has established five share incentive programs as discussed in Note 10. Stock-based awards exchanged for services are accounted for under the fair value method. Accordingly, stock-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date. Determining the fair value of share-based awards at the grant date requires assumptions and judgments about expected volatility, among other factors. Stock-based compensation costs of $386,000 and $303,000 were recognized for the three months ended December 31, 2024 and 2023, respectively. Stock-based compensation costs of $757,000 and $610,000 were recognized for the six months ended December 31, 2024 and 2023, respectively.
Foreign Currency	Foreign Currency The Company has determined the functional currency of all foreign subsidiaries is the U.S. Dollar. All foreign operations are considered a direct and integral part or extension of the Company’s operations. The day-to-day operations of all foreign subsidiaries are dependent on the economic environment of the U.S. Dollar. Therefore, no realized and unrealized gains and losses associated with foreign currency translation are recorded for the three and six months ended December 31, 2024 or 2023.
Segment Reporting	Segment Reporting The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture and sales of high-tech security devices and related cellular communication services for the devices. The Company’s Chief Operating Decision Maker, (the President, Chief Operating Officer, and Chief Financial Officer) evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results. The Company has presented required geographical data in Note 14.
Leases	Leases The Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. If the Company has options to renew or terminate certain leases, those options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less. See Note 13 – Commitments and Contingencies; Leases for additional accounting policies and disclosures.
Legal and Other Contingencies	Legal and Other Contingencies The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty. An estimated loss from a loss contingency such as a legal proceeding or claim is accrued by a charge to income if it is probable that an asset has been impaired, or a liability has been incurred and the amount of the loss can be reasonably estimated. In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted	Recent Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . The update expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. It further requires disclosure of the amount and description of its composition for other segment items, and interim disclosures of both a reportable segment’s profit or loss and assets. The guidance requires disclosure of the title and position of the chief operating decision maker and how reported measures of segment profit or loss are used to assess performance and allocate resources. This pronouncement is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public entities to disclose consistent categories and greater disaggregation of information in the rate reconciliation and for income taxes paid. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements. The Company is evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Nature of Business and Summar_3

Nature of Business and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2024
Nature of Business and Summary of Significant Accounting Policies
Schedule of cash and cash equivalents	Cash and cash equivalents consist of the following as of (in thousands): December 31, 2024 June 30, 2024 Cash $ 11,399 $ 18,823 Money Market Fund 72,095 41,116 U.S. Treasury Securities 2,525 — Certificate of Deposits — 5,402 $ 86,019 $ 65,341
Schedule of investments - other	Investments-other consists of the following as of (in thousands): December 31, 2024 June 30, 2024 Certificate of Deposits $ — $ 26,980 $ — $ 26,980
Schedule of certificates of deposit	Certificates of deposit are recorded at the original cost plus accrued interest. There were no certificate of deposits outstanding at December 31, 2024. The Company’s certificates of deposits as of June 30, 2024 consist of the following (in thousands): June 30, 2024 Balance Sheet Classification Interest Rate Maturity Date Cost Carrying Value Cash and Cash Equivalents 4.70% 8/22/2024 $ 5,374 $ 5,402 Investments - other 4.55% - 4.75% 7/25/2024 - 10/24/2024 26,709 26,980
Schedule of intangible assets	Intangible assets consisted of the follows (in thousands): December 31, 2024 June 30, 2024 Carrying Accumulated Net book Carrying Accumulated Net book value amortization value value amortization value Customer relationships $ 9,800 $ (9,492) $ 308 $ 9,800 $ (9,436) $ 364 Trade name 4,048 (911) 3,137 4,048 (810) 3,238 $ 13,848 $ (10,403) $ 3,445 $ 13,848 $ (10,246) $ 3,602
Schedule of reconciliation of earnings per share	The following provides a reconciliation of information used in calculating the per share amounts for the three months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income Weighted Average Shares Net Income per Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 10,467 $ 12,610 36,538 36,829 $ 0.29 $ 0.34 Effect of Dilutive Securities: Stock Options — — 238 189 (0.01) — Diluted EPS $ 10,467 $ 12,610 36,776 37,018 $ 0.28 $ 0.34 The following provides a reconciliation of information used in calculating the per share amounts for the six months ended December 31, 2024 and 2023 (in thousands, except share and per share data): Net Income per Net Income Weighted Average Shares Share 2024 2023 2024 2023 2024 2023 Basic EPS $ 21,652 $ 23,088 36,706 36,743 $ 0.59 $ 0.63 Effect of Dilutive Securities: Stock Options — — 277 219 — (0.01) Diluted EPS $ 21,652 $ 23,088 36,983 36,962 $ 0.59 $ 0.62

Revenue Recognition and Contr_2

Revenue Recognition and Contracts with Customers (Tables)	6 Months Ended
Revenue Recognition and Contracts with Customers (Tables)	Dec. 31, 2024
Revenue Recognition and Contracts with Customers
Schedule of disaggregation of revenues	Following is the disaggregation of revenues based on major product lines (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Major Product Lines: Intrusion and access alarm products $ 7,556 $ 11,258 $ 16,619 $ 20,554 Door locking devices 14,169 17,749 28,023 32,844 Services 21,208 18,540 42,294 35,825 Total Revenues $ 42,933 $ 47,547 $ 86,936 $ 89,223

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	6 Months Ended
Fair Value Measurement (Tables)	Dec. 31, 2024
Fair Value Measurement
Schedule of company's assets that were measured at fair value	Level 1 Level 2 Level 3 Total December 31, 2024 Cash equivalents U.S. Treasury Securities 2,525,000 - - 2,525,000 Money market funds 72,095,000 - - 72,095,000 Total 74,620,000 - - 74,620,000 Marketable securities U.S. Treasury Securities 7,528,000 - - 7,528,000 Mutual funds 5,648,000 - - 5,648,000 Total 13,176,000 - - 13,176,000 June 30, 2024 Cash equivalents Certificate of deposits 5,402,000 - - 5,402,000 Money market funds 41,116,000 - - 41,116,000 Total 46,518,000 - - 46,518,000 Short-term investments Certificate of deposits 26,980,000 - - 26,980,000 Total 26,980,000 - - 26,980,000 Marketable securities Mutual funds 5,398,000 - - 5,398,000 Total 5,398,000 - - 5,398,000

Marketable Securities (Tables)

Marketable Securities (Tables)	6 Months Ended
Marketable Securities (Tables)	Dec. 31, 2024
Marketable Securities
Schedule of investment in marketable securities	A summary of the fair value of the Company’s investment in marketable securities as of December 31, 2024 and June 30, 2024 is as follows: December 31, 2024 June 30, 2024 Equity Securities $ 5,648 $ 5,398 Debt Securities (available-for-sale) 7,528 — $ 13,176 $ 5,398
Schedule of net gains and losses on the equity securities	The disaggregated net gains and losses on the equity securities recognized within the accompanying condensed consolidated statements of income for the three and six months ended December 31, 2024 and 2023, are as follows (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Net gains recognized during the period on equity securities $ 57 $ 75 $ 168 $ 117 Less: Net income (losses) recognized during the period on equity securities sold during the period — — — — Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date (76) 128 81 71 $ (19) $ 203 $ 249 $ 188
Schedule of investments in equity securities	Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Net gains recognized during the period on equity securities $ 57 $ 75 $ 168 $ 117 Less: Net income (losses) recognized during the period on equity securities sold during the period — — — — Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date (76) 128 81 71 $ (19) $ 203 $ 249 $ 188
Schedule of investment in debt securities	The Company had no investment in debt securities at June 30, 2024. The following tables summarize the Company’s investments in debt securities at December 31, 2024 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. Treasury Securities $ 9,976 $ 53 $ — $ 10,029 Included in Cash and cash equivalents $ 2,501 $ - $ — $ 2,501 Included in Marketable securities $ 7,475 $ 53 $ — $ 7,528

Inventories (Tables)

Inventories (Tables)	6 Months Ended
Inventories (Tables)	Dec. 31, 2024
Inventories
Schedule of inventory	Inventories, net of reserves are valued at lower of cost (first-in, first-out method) or net realizable value. Inventories, net of reserves consist of the following (in thousands): December 31, June 30, 2024 2024 Component parts $ 32,203 $ 32,283 Work-in-process 7,607 7,509 Finished product 9,864 10,121 $ 49,674 $ 49,913 Classification of inventories: Current $ 37,634 $ 34,804 Non-current 12,040 15,109 $ 49,674 $ 49,913

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	6 Months Ended
Property, Plant, and Equipment (Tables)	Dec. 31, 2024
Property, Plant, and Equipment
Schedule of property, plant and equipment	Property, plant and equipment consist of the following (in thousands): December 31, 2024 June 30, 2024 Useful Life in Years Land $ 904 $ 904 N/A Buildings 8,911 8,911 30 to 40 Molds and dies 7,548 7,539 3 to 5 Furniture and fixtures 3,702 3,613 5 to 10 Machinery and equipment 30,854 29,761 3 to 10 Building improvements 3,657 3,129 Shorter of the lease term or life of asset 55,576 53,857 Less: accumulated depreciation and amortization (45,661) (44,780) $ 9,915 $ 9,077

Stock Options (Tables)

Stock Options (Tables)	6 Months Ended
Stock Options (Tables)	Dec. 31, 2024
2012 Employee Stock Option Plan
Stock Options
Schedule of plan activity	2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 363,036 $ 21.47 521,580 $ 19.37 Forfeited/Lapsed — — (11,000) $ 3.15 Exercised (2,000) $ 26.94 (31,600) $ 22.13 Outstanding, end of period 361,036 $ 21.44 478,980 $ 19.56 Exercisable, end of period 265,660 $ 21.36 289,728 $ 18.58 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised $ 35,000 $ 375,000 Total intrinsic value of options outstanding $ 5,100,000 $ 7,034,000 Total intrinsic value of options exercisable $ 3,772,000 $ 4,539,000
Schedule of options outstanding	Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $10.02 ‑ $26.94 361,036 6.65 $ 21.44 265,660 $ 21.36 361,036 6.65 $ 21.44 265,660 $ 21.36
2012 Non-Employee Stock Option Plan
Stock Options
Schedule of plan activity	2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 20,400 $ 14.39 20,400 $ 14.39 Forfeited/Lapsed — — — — Exercised — — — — Outstanding, end of period 20,400 $ 14.39 20,400 $ 14.39 Exercisable, end of period 18,480 $ 13.50 15,840 $ 12.44 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised n/a n/a Total intrinsic value of options outstanding $ 432,000 $ 405,000 Total intrinsic value of options exercisable $ 408,000 $ 345,000
Schedule of options outstanding	Options outstanding Options exercisable Weighted average Weighted Weighted Number remaining average exercise Number average exercise Range of exercise prices outstanding contractual life price exercisable price $4.35 - $22.93 20,400 5.14 $ 14.39 18,480 $ 13.50 20,400 5.14 $ 14.39 18,480 $ 13.50
2018 Non-Employee Stock Option Plan
Stock Options
Schedule of plan activity	2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 68,900 $ 14.54 75,000 $ 14.83 Granted — — — — Forfeited/Lapsed (4,000) $ 22.93 — — Exercised — (1,600) $ 15.27 Outstanding, end of period 64,900 $ 14.02 73,400 $ 14.82 Exercisable, end of period 62,200 $ 13.63 58,620 $ 13.81 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised n/a $ 28,000 Total intrinsic value of options outstanding $ 1,398,000 $ 1,426,000 Total intrinsic value of options exercisable $ 1,364,000 $ 1,198,000
Schedule of options outstanding	Options outstanding Options exercisable Weighted average Weighted Weighted Number remaining average exercise Number average exercise Range of exercise prices outstanding contractual life price exercisable price $8.10 - $22.93 64,900 5.10 $ 14.02 62,200 $ 13.63 64,900 5.10 $ 14.02 62,200 $ 13.63
2020 Non-Employee Stock Option Plan
Stock Options
Schedule of plan activity	2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 56,900 $ 23.35 56,900 $ 23.35 Granted — — — — Forfeited/Lapsed (2,000) $ 26.94 — — Exercised (3,000) $ 26.94 — — Outstanding, end of period 51,900 $ 23.00 56,900 $ 23.35 Exercisable, end of period 37,520 $ 21.55 29,140 $ 21.41 Weighted average fair value at grant date of options granted n/a n/a Total intrinsic value of options exercised $ 32,000 n/a Total intrinsic value of options outstanding $ 652,000 $ 620,000 Total intrinsic value of options exercisable $ 525,000 $ 374,000
Schedule of options outstanding	Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $11.40 - $30.71 51,900 7.03 $ 23.00 37,520 $ 21.55 51,900 7.03 $ 23.00 37,520 $ 21.55
2022 Employee Stock Option Plan
Stock Options
Schedule of fair value and valuation assumptions	2024 2023 Risk-free interest rates n/a 4.66 % Expected lives n/a 5.76 Years Expected volatility n/a 48.71 % Expected dividend yields n/a 1.48 %
Schedule of plan activity	2024 2023 Weighted average Weighted average Options exercise price Options exercise price Outstanding, beginning of year 130,000 $ 41.38 5,000 $ 40.01 Granted — — 10,000 $ 21.60 Forfeited/Lapsed — — (5,000) $ 40.01 Exercised — — — — Outstanding, end of period 130,000 $ 41.38 10,000 $ 21.60 Exercisable, end of period 28,000 $ 39.96 2,000 $ 21.60 Weighted average fair value at grant date of options granted n/a $ 9.75 Total intrinsic value of options exercised n/a n/a Total intrinsic value of options outstanding $ 140,000 $ 127,000 Total intrinsic value of options exercisable $ 56,000 $ 25,300
Schedule of options outstanding	Options outstanding Options exercisable Weighted average Number remaining Weighted average Number Weighted average Range of exercise prices outstanding contractual life exercise price exercisable exercise price $21.60 - $49.39 130,000 9.30 $ 41.38 28,000 $ 39.96 130,000 9.30 $ 41.38 28,000 $ 39.96

Stockholders' Equity Transact_2

Stockholders' Equity Transactions (Tables)	6 Months Ended
Stockholders' Equity Transactions (Tables)	Dec. 31, 2024
Stockholders' Equity Transactions
Schedule of dividends payable	The following tables summarizes information about dividends declared by the Company for the six months ended December 31, 2024 and the fiscal year ended June 30, 2024: Dividend Declaration Date Stockholders of Record Date Dividend Payable Date Per Share Cash Dividend Amount November 1, 2024 December 12, 2024 January 3, 2025 $0.125 August 22, 2024 September 12, 2024 October 3, 2024 $0.125 May 2, 2024 June 3, 2024 June 24, 2024 $ 0.10 February 1, 2024 March 1, 2024 March 22, 2024 $ 0.10 November 2, 2023 December 1, 2023 December 22, 2023 $ 0.08 August 18, 2023 September 1, 2023 September 22, 2023 $ 0.08
Schedule of shares repurchased	The following tables summarizes information about shares repurchased by the Company for the six months ended December 31, 2024: Total Number of Maximum Total Shares Purchased as Number of Shares Number of Average Part of Publicly that May Yet Be Shares Price Paid Announced Plans or Purchased Under Period Purchased per Share Programs Plans or Programs September 10, 2024 - September 19, 2024 193,252 $ 37.67 193,252 1,104,741 November 7, 2024 - December 19, 2024 282,647 $ 37.95 282,647 1,104,741 Total for the 6 months ended December 31, 2024 475,899 $ 37.84 475,899 1,104,741

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2024
Commitments and Contingencies.
Schedule of supplemental balance sheet information	Weighted-average remaining lease term 67 Years Weighted-average discount rate 6.25 %
Schedule of maturities of lease liabilities	The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2024 (in thousands): Year Ending June 30, Amount 2025 $ 172 2026 346 2027 349 2028 351 2029 353 Thereafter 29,665 Total future minimum lease payments $ 31,236 Less: Imputed interest 25,901 Total $ 5,335

Geographical Data (Tables)

Geographical Data (Tables)	6 Months Ended
Geographical Data (Tables)	Dec. 31, 2024
Geographical Data
Schedule of sales to external customers	Financial Information Relating to Domestic and Foreign Operations (in thousands): Three months ended December 31, Six months ended December 31, 2024 2023 2024 2023 Sales to external customers (1) Domestic $ 42,679 $ 47,291 $ 86,367 $ 88,661 Foreign 254 256 569 562 Total Net Sales $ 42,933 $ 47,547 $ 86,936 $ 89,223 (1) All of the Company’s sales originate in the United States and are shipped primarily from the Company’s facilities in the United States. There were no sales into any one foreign country in excess of 10% of total Net Sales.
Schedule of assets in individual foreign country by country	December 31, 2024 June 30, 2024 Identifiable assets: United States $ 160,536 $ 164,365 Dominican Republic (2) 42,148 43,387 Total Identifiable Assets $ 202,684 $ 207,752 Consists primarily of inventories (December 31, 2024 = $31,864 ; June 30, 2024 = $33,584 ), operating lease right of use (December 31, 2024 = $5,335 ; June 30, 2024 = $5,487 ) and fixed assets (December 31, 2024 = $4,312 ; June 30, 2024 = $3,623 ) located at the Company’s principal manufacturing facility in the Dominican Republic.

Nature of Business and Summar_4

Nature of Business and Summary of Significant Accounting Policies (Details)	3 Months Ended		6 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Jun. 30, 2024 USD ($)
Accounting policies
Allowance for credit losses	$ 20,000		$ 20,000		$ 32,000
Stock-Based Compensation
Number of share incentive programs			five
Stock based compensation expense	386,000	$ 303,000	$ 757,000	$ 610,000
Foreign currency realized/unrealized gains(loss)	$ 0	$ 0	$ 0	$ 0
Segment Reporting
Number of operating segments (in segments) \| segment			1
Number of reportable segments (in segments) \| segment			1
Minimum
Accounting policies
Warranty term	24 months		24 months
Maximum
Accounting policies
Warranty term	36 months		36 months

Nature of Business and Summar_5

Nature of Business and Summary of Significant Accounting Policies - Cash and Cash Equivalents and Investments (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Accounting policies
Cash and cash equivalents	$ 86,019,000	$ 65,341,000
Investments - other		26,980,000
Cash and Cash Equivalents
Accounting policies
Cost		5,374,000
Carrying Value		5,402,000
Investments - other
Accounting policies
Cost		26,709,000
Carrying Value		26,980,000
Certificate of Deposits
Accounting policies
Investments - other	0	$ 26,980,000
Certificate of Deposits \| Cash and Cash Equivalents
Accounting policies
Interest Rate		4.70%
Certificate of Deposits \| Investments - other \| Minimum
Accounting policies
Interest Rate		4.55%
Certificate of Deposits \| Investments - other \| Maximum
Accounting policies
Interest Rate		4.75%
Cash
Accounting policies
Cash and cash equivalents	11,399,000	$ 18,823,000
Money Market Fund
Accounting policies
Cash and cash equivalents	72,095,000	41,116,000
U.S. Treasury Securities
Accounting policies
Cash and cash equivalents	2,525,000
Certificate of Deposits
Accounting policies
Cash and cash equivalents		5,402,000
Short Term Time Deposits Member
Accounting policies
Cash and cash equivalents	$ 74,620,000	$ 46,518,000

Nature of Business and Summar_6

Nature of Business and Summary of Significant Accounting Policies - Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Intangible assets
Amortization expense	$ 79,000	$ 84,000	$ 157,000	$ 168,000
Changes in intangible assets
Carrying value	13,848,000		13,848,000		$ 13,848,000
Accumulated amortization	(10,403,000)		(10,403,000)		(10,246,000)
Net book value	3,445,000		3,445,000		$ 3,602,000
Future amortization expense
2026	297,000		297,000
2027	283,000		283,000
2028	269,000		269,000
2029	210,000		210,000
2030	202,000		$ 202,000
Weighted average remaining period			14 years 4 months 24 days		14 years 9 months 18 days
Customer relationships
Changes in intangible assets
Carrying value	9,800,000		$ 9,800,000		$ 9,800,000
Accumulated amortization	(9,492,000)		(9,492,000)		(9,436,000)
Net book value	308,000		308,000		364,000
Trade name
Changes in intangible assets
Carrying value	4,048,000		4,048,000		4,048,000
Accumulated amortization	(911,000)		(911,000)		(810,000)
Net book value	$ 3,137,000		$ 3,137,000		$ 3,238,000

Nature of Business and Summar_7

Nature of Business and Summary of Significant Accounting Policies - Income Statement location (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Net sales	$ 42,933,000	$ 47,547,000	$ 86,936,000	$ 89,223,000
Cost of sales	18,444,000	22,535,000	37,831,000	41,798,000
Selling, General and Administrative Expenses
Advertising and promotion costs	916,000	696,000	1,806,000	1,457,000
Cost of sales \| Shipping and Handling
Cost of sales	353,000	389,000	743,000	760,000
Sales revenue, net \| Shipping and Handling
Net sales	$ 80,000	$ 103,000	$ 170,000	$ 186,000

Nature of Business and Summar_8

Nature of Business and Summary of Significant Accounting Policies - Net Income per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Net Income
Basic EPS	$ 10,467	$ 12,610	$ 21,652	$ 23,088
Diluted EPS	$ 10,467	$ 12,610	$ 21,652	$ 23,088
Weighted average
Weighted Average Shares, Basic EPS	36,538,000	36,829,000	36,706,000	36,743,000
Weighted Average Shares, Stock Options	238,000	189,000	277,000	219,000
Weighted Average Shares, Diluted EPS	36,776,000	37,018,000	36,983,000	36,962,000
Net Income per Share
Basic (in dollars per share)	$ 0.29	$ 0.34	$ 0.59	$ 0.63
Stock Options (in dollars per share)	(0.01)			(0.01)
Diluted (in dollars per share)	$ 0.28	$ 0.34	$ 0.59	$ 0.62
Excluded from diluted EPS	120,000	67,500	70,000	36,250

Revenue Recognition and Contr_3

Revenue Recognition and Contracts with Customers (Details)	3 Months Ended		6 Months Ended
Revenue Recognition and Contracts with Customers (Details)	Dec. 31, 2024 USD ($)	Dec. 31, 2023	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023	Jun. 30, 2024 USD ($)
Revenue:
Number of operating segments (in segments) \| segment			1
Sales returns, rebates and allowances as a percentage of gross sales	4%	6%	7%	5%
Current Liabilities
Revenue:
Refund liabilities	$ 4,814,000		$ 4,814,000		$ 6,295,000
Other current assets
Revenue:
Return-related assets	$ 1,263,000		$ 1,263,000		$ 1,586,000

Revenue Recognition and Contr_4

Revenue Recognition and Contracts with Customers - Disaggregation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Revenue:
Revenues	$ 42,933	$ 47,547	$ 86,936	$ 89,223
Intrusion and access alarm products
Revenue:
Revenues	7,556	11,258	16,619	20,554
Door locking devices
Revenue:
Revenues	14,169	17,749	28,023	32,844
Services
Revenue:
Revenues	$ 21,208	$ 18,540	$ 42,294	$ 35,825

Business and Credit Concentra_2

Business and Credit Concentrations (Details) - Accounts Receivable - Credit Concentration Risk - customer	6 Months Ended	12 Months Ended
	Dec. 31, 2024	Jun. 30, 2024
Business and Credit Concentrations
Number of customers	2	2
Customer One
Business and Credit Concentrations
Number of customers	1
Concentration risk (as a percent)	11%	17%
Customer Two
Business and Credit Concentrations
Concentration risk (as a percent)	13%	12%
Customer Three
Business and Credit Concentrations
Concentration risk (as a percent)	13%

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($)	3 Months Ended		6 Months Ended
Fair Value Measurement (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Marketable Securities:
Short-term investments					$ 26,980,000
Fair Value					0
Transfers between Level 1 to 2	$ 0	$ 0	$ 0	$ 0
Transfers in or out of level 3	0	$ 0	0	$ 0
Fair Value, Recurring
Marketable Securities:
Cash equivalents	74,620,000		74,620,000		46,518,000
Short-term investments					26,980,000
Fair Value	13,176,000		13,176,000		5,398,000
Fair Value, Recurring \| U.S. Treasury Securities
Marketable Securities:
Cash equivalents	2,525,000		2,525,000
Fair Value	7,528,000		7,528,000
Fair Value, Recurring \| Certificate of Deposits
Marketable Securities:
Cash equivalents					5,402,000
Short-term investments					26,980,000
Fair Value, Recurring \| Money Market Fund
Marketable Securities:
Cash equivalents	72,095,000		72,095,000		41,116,000
Fair Value, Recurring \| Mutual Funds
Marketable Securities:
Fair Value	5,648,000		5,648,000		5,398,000
Fair Value, Recurring \| Level 1
Marketable Securities:
Cash equivalents	74,620,000		74,620,000		46,518,000
Short-term investments					26,980,000
Fair Value	13,176,000		13,176,000		5,398,000
Fair Value, Recurring \| Level 1 \| U.S. Treasury Securities
Marketable Securities:
Cash equivalents	2,525,000		2,525,000
Fair Value	7,528,000		7,528,000
Fair Value, Recurring \| Level 1 \| Certificate of Deposits
Marketable Securities:
Cash equivalents					5,402,000
Short-term investments					26,980,000
Fair Value, Recurring \| Level 1 \| Money Market Fund
Marketable Securities:
Cash equivalents	72,095,000		72,095,000		41,116,000
Fair Value, Recurring \| Level 1 \| Mutual Funds
Marketable Securities:
Fair Value	$ 5,648,000		$ 5,648,000		$ 5,398,000

Marketable Securities - Investm

Marketable Securities - Investment in marketable securities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Marketable Securities
Equity Securities	$ 5,648	$ 5,398
Debt Securities (available-for-sale)	7,528
Marketable Securities, Current, Total	$ 13,176	$ 5,398

Marketable Securities - Inves_2

Marketable Securities - Investments in net gains and losses on the equity securities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Marketable Securities
Net gains recognized during the period on equity securities	$ 57	$ 75	$ 168	$ 117
Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date	(76)	128	81	71
Equity Securities, FV-NI, Gain (Loss)	$ (19)	$ 203	$ 249	$ 188

Marketable Securities - Inves_3

Marketable Securities - Investments in equity securities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Net Investment Income [Line Items]
Fair Value		$ 0
Mutual Funds
Net Investment Income [Line Items]
Cost	$ 5,899	5,857
Fair Value	5,648	5,398
Unrealized Gain (Loss)	$ (251)	$ (459)

Marketable Securities - Inves_4

Marketable Securities - Investments in debt securities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Investments in Debt Securities
Aggregate Fair Value		$ 0
Included in Cash and cash equivalents
Investments in Debt Securities
Amortized Cost	$ 2,501
Unrealized Losses	0
Aggregate Fair Value	2,501
Included in Marketable securities
Investments in Debt Securities
Amortized Cost	7,475
Unrealized Gains	53
Unrealized Losses	0
Aggregate Fair Value	7,528
U.S. Treasury Securities
Investments in Debt Securities
Amortized Cost	9,976
Unrealized Gains	53
Unrealized Losses	0
Aggregate Fair Value	$ 10,029

Inventories - Types (Details)

Inventories - Types (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Inventories
Component parts	$ 32,203	$ 32,283
Work-in-process	7,607	7,509
Finished product	9,864	10,121
Inventories	$ 49,674	$ 49,913

Inventories - Classification (D

Inventories - Classification (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Inventories
Current	$ 37,634	$ 34,804
Non-current	12,040	15,109
Inventories	$ 49,674	$ 49,913

Inventories - Excess and slow-m

Inventories - Excess and slow-moving inventory (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Excess and slow-moving inventory and net realizable value reserve
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Reserve for excess and slow-moving inventory	$ 4,800,000	$ 5,026,000

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($)	3 Months Ended		6 Months Ended
Property, Plant, and Equipment (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Property plant and equipment
Gross	$ 55,576,000		$ 55,576,000		$ 53,857,000
Less: accumulated depreciation and amortization	(45,661,000)		(45,661,000)		(44,780,000)
Net	9,915,000		9,915,000		9,077,000
Depreciation and amortization	506,000	$ 467,000	976,000	$ 920,000
Land
Property plant and equipment
Gross	904,000		904,000		904,000
Buildings
Property plant and equipment
Gross	$ 8,911,000		$ 8,911,000		8,911,000
Buildings \| Minimum
Property plant and equipment
Useful life	30 years		30 years
Buildings \| Maximum
Property plant and equipment
Useful life	40 years		40 years
Molds and dies
Property plant and equipment
Gross	$ 7,548,000		$ 7,548,000		7,539,000
Molds and dies \| Minimum
Property plant and equipment
Useful life	3 years		3 years
Molds and dies \| Maximum
Property plant and equipment
Useful life	5 years		5 years
Furniture and fixtures
Property plant and equipment
Gross	$ 3,702,000		$ 3,702,000		3,613,000
Furniture and fixtures \| Minimum
Property plant and equipment
Useful life	5 years		5 years
Furniture and fixtures \| Maximum
Property plant and equipment
Useful life	10 years		10 years
Machinery and equipment
Property plant and equipment
Gross	$ 30,854,000		$ 30,854,000		29,761,000
Machinery and equipment \| Minimum
Property plant and equipment
Useful life	3 years		3 years
Machinery and equipment \| Maximum
Property plant and equipment
Useful life	10 years		10 years
Building improvements
Property plant and equipment
Gross	$ 3,657,000		$ 3,657,000		$ 3,129,000
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember		us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember

Income Taxes - Income (loss) be

Income Taxes - Income (loss) before income taxes attributable to domestic and foreign operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Taxes
Domestic			$ 4,306,000
Foreign			20,786,000
Income before Provision for Income Taxes	$ 12,092,000	$ 14,534,000	$ 25,092,000	$ 26,529,000

Income Taxes (Details)

Income Taxes (Details)	6 Months Ended
Income Taxes (Details)	Dec. 31, 2024 USD ($)
Income Taxes
Accrued interest on income taxes	$ 229,000
Unrecognized net tax benefits	754,000
Additional tax liability	54,000
Additional interest expense accrued	$ 35,000

Long-Term Debt (Details)

Long-Term Debt (Details) - USD ($)	6 Months Ended
Long-Term Debt (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024	Feb. 09, 2024	Feb. 08, 2024	Jun. 30, 2020
The Revolver Agreement
Long-Term Debt
Line of credit, maximum borrowing capacity			$ 20,000,000	$ 11,000,000
Revolving line of credit	$ 0	$ 0
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	us-gaap:SecuredOvernightFinancingRateSofrMember
Stock collateral (as a percent)	65%
The Revolver Agreement \| Minimum
Long-Term Debt
Basis spread	1.2645%
The Revolver Agreement \| Maximum
Long-Term Debt
Basis spread	1.3645%
Paycheck Protection Program
Long-Term Debt
Principal amount					$ 3,904,000

Stock Options - Plan Informatio

Stock Options - Plan Information (Details) - USD ($)	1 Months Ended				3 Months Ended		6 Months Ended
Stock Options - Plan Information (Details) - USD ($)	Dec. 31, 2022	May 31, 2020	Dec. 31, 2018	Dec. 31, 2012	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Stock Options
Stock-based compensation expense, allocated					$ 386,000	$ 335,000	$ 757,000	$ 610,000
Basic earnings per share from share based compensation costs					$ 0.01	$ 0.01	$ 0.02	$ 0.01
Diluted earnings per share from share based compensation costs					$ 0.01	$ 0.01	$ 0.02	$ 0.01
Proceeds from stock option exercises							$ 54,000
2012 Employee Stock Option Plan
Stock Options
Shares authorized (in shares)				1,900,000
Threshold percentage of voting rights				10%
Premium on fair market value (as a percent)				110%
Term				10 years
Vesting rights percentage				20%
Outstanding (in shares)					361,036	478,980	361,036	478,980	363,036	521,580
Exercisable, end of period					265,660	289,728	265,660	289,728
Available for grant (in shares)					0		0
Exercised					0	31,600	2,000	31,600
Number of Stock options settled by withholding of shares						31,600		31,600
Shares withheld						20,567		20,567
Proceeds from stock option exercises						$ 0	$ 54,000	$ 0
Deferred tax benefit					$ 0	$ 52,000	0	$ 52,000
Unearned stock based compensation					$ 677,000		$ 677,000
Vested					67,600	74,000	76,700	84,700
Fair Value					$ 670,000	$ 724,000	$ 782,000	$ 849,000
2012 Non-Employee Stock Option Plan
Stock Options
Shares authorized (in shares)				100,000
Term				10 years
Vesting rights percentage				20%
Outstanding (in shares)					20,400	20,400	20,400	20,400	20,400	20,400
Exercisable, end of period					18,480	15,840	18,480	15,840
Available for grant (in shares)					0		0
Proceeds from stock option exercises					$ 0	$ 0	$ 0	$ 0
Deferred tax benefit					0	$ 0	0	$ 0
Unearned stock based compensation					$ 15,000		$ 15,000
Vested					1,920	1,920	1,920	1,920
Fair Value					$ 19,000	$ 19,000	$ 19,000	$ 19,000
2018 Non-Employee Stock Option Plan
Stock Options
Shares authorized (in shares)			100,000
Term			10 years
Vesting rights percentage			20%
Outstanding (in shares)					64,900	73,400	64,900	73,400	68,900	75,000
Exercisable, end of period					62,200	58,620	62,200	58,620
Available for grant (in shares)					4,000		4,000
Granted							0	0
Exercised						1,600	0	1,600
Number of Stock options settled by withholding of shares						1,600		1,600
Shares withheld						740		740
Proceeds from stock option exercises					$ 0	$ 0	$ 0	$ 0
Deferred tax benefit					0	$ 6,000	0	$ 6,000
Unearned stock based compensation					$ 20,000		$ 20,000
Vested					2,700	9,500	2,700	9,500
Fair Value					$ 27,000	$ 89,000	$ 27,000	$ 89,000
2018 Non-Employee Stock Option Plan \| Options granted after December 2028
Stock Options
Granted							0
2020 Non-Employee Stock Option Plan
Stock Options
Shares authorized (in shares)		100,000
Term		10 years
Vesting rights percentage		20%
Outstanding (in shares)					51,900	56,900	51,900	56,900	56,900	56,900
Exercisable, end of period					37,520	29,140	37,520	29,140
Available for grant (in shares)					45,100		45,100
Granted							0	0
Exercised					0	0	3,000	0
Number of Stock options settled by withholding of shares							3,000
Shares withheld							2,151
Proceeds from stock option exercises						$ 0		$ 0
Deferred tax benefit					$ 0	$ 0	$ 7,000	$ 0
Unearned stock based compensation					$ 137,000		$ 137,000
Vested					3,380	3,380	10,380	10,380
Fair Value					$ 34,000	$ 34,000	$ 113,000	$ 113,000
2020 Non-Employee Stock Option Plan \| Options granted after May 2030
Stock Options
Granted							0
2022 Employee Stock Option Plan
Stock Options
Shares authorized (in shares)	950,000
Threshold percentage of voting rights	10%
Premium on fair market value (as a percent)	110%
Term	10 years
Vesting rights percentage	20%
Outstanding (in shares)					130,000		130,000		130,000
Exercisable, end of period					28,000		28,000
Available for grant (in shares)					820,000		820,000
Granted						10,000	0	10,000
Proceeds from stock option exercises					$ 0	$ 0	$ 0	$ 0
Deferred tax benefit					0	$ 0	0	$ 0
Unearned stock based compensation					$ 1,816,000		$ 1,816,000
Vested					2,000	2,000	2,000	2,000
Fair Value					$ 19,500	$ 19,500	$ 19,500	$ 19,500
2022 Employee Stock Option Plan \| Options granted after December 2032
Stock Options
Granted							0

Stock Options - Fair Value Assu

Stock Options - Fair Value Assumptions (Details) - 2022 Employee Stock Option Plan	6 Months Ended
	Dec. 31, 2023
Stock Options
Risk-free interest rates	4.66%
Expected lives	5 years 9 months 3 days
Expected volatility	48.71%
Expected dividend yields	1.48%

Stock Options - Activity (Detai

Stock Options - Activity (Details) - USD ($)	3 Months Ended		6 Months Ended
Stock Options - Activity (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
2012 Employee Stock Option Plan
Options
Outstanding, beginning of year			363,036	521,580
Forfeited/Lapsed				(11,000)
Exercised	0	(31,600)	(2,000)	(31,600)
Outstanding, end of period	361,036	478,980	361,036	478,980
Exercisable, end of period	265,660	289,728	265,660	289,728
Weighted average exercise price
Weighted average exercise price, beginning of year			$ 21.47	$ 19.37
Forfeited/Lapsed (per share)				3.15
Exercised (per share)			26.94	22.13
Weighted average exercise price, end of period	$ 21.44	$ 19.56	21.44	19.56
Exercisable, end of period, weighted average exercise price	$ 21.36	$ 18.58	$ 21.36	$ 18.58
Additional disclosures
Total intrinsic value of options exercised			$ 35,000	$ 375,000
Total intrinsic value of options outstanding	$ 5,100,000	$ 7,034,000	5,100,000	7,034,000
Total intrinsic value of options exercisable	$ 3,772,000	$ 4,539,000	$ 3,772,000	$ 4,539,000
2012 Non-Employee Stock Option Plan
Options
Outstanding, beginning of year			20,400	20,400
Outstanding, end of period	20,400	20,400	20,400	20,400
Exercisable, end of period	18,480	15,840	18,480	15,840
Weighted average exercise price
Weighted average exercise price, beginning of year			$ 14.39	$ 14.39
Weighted average exercise price, end of period	$ 14.39	$ 14.39	14.39	14.39
Exercisable, end of period, weighted average exercise price	$ 13.5	$ 12.44	$ 13.5	$ 12.44
Additional disclosures
Total intrinsic value of options outstanding	$ 432,000	$ 405,000	$ 432,000	$ 405,000
Total intrinsic value of options exercisable	$ 408,000	$ 345,000	$ 408,000	$ 345,000
2018 Non-Employee Stock Option Plan
Options
Outstanding, beginning of year			68,900	75,000
Granted			0	0
Forfeited/Lapsed			(4,000)
Exercised		(1,600)	0	(1,600)
Outstanding, end of period	64,900	73,400	64,900	73,400
Exercisable, end of period	62,200	58,620	62,200	58,620
Weighted average exercise price
Weighted average exercise price, beginning of year			$ 14.54	$ 14.83
Forfeited/Lapsed (per share)			22.93
Exercised (per share)				15.27
Weighted average exercise price, end of period	$ 14.02	$ 14.82	14.02	14.82
Exercisable, end of period, weighted average exercise price	$ 13.63	$ 13.81	$ 13.63	$ 13.81
Additional disclosures
Total intrinsic value of options exercised				$ 28,000
Total intrinsic value of options outstanding	$ 1,398,000	$ 1,426,000	$ 1,398,000	1,426,000
Total intrinsic value of options exercisable	$ 1,364,000	$ 1,198,000	$ 1,364,000	$ 1,198,000
2020 Non-Employee Stock Option Plan
Options
Outstanding, beginning of year			56,900	56,900
Granted			0	0
Forfeited/Lapsed			(2,000)
Exercised	0	0	(3,000)	0
Outstanding, end of period	51,900	56,900	51,900	56,900
Exercisable, end of period	37,520	29,140	37,520	29,140
Weighted average exercise price
Weighted average exercise price, beginning of year			$ 23.35	$ 23.35
Forfeited/Lapsed (per share)			26.94
Exercised (per share)			26.94
Weighted average exercise price, end of period	$ 23	$ 23.35	23	23.35
Exercisable, end of period, weighted average exercise price	$ 21.55	$ 21.41	$ 21.55	$ 21.41
Additional disclosures
Total intrinsic value of options exercised			$ 32,000
Total intrinsic value of options outstanding	$ 652,000	$ 620,000	652,000	$ 620,000
Total intrinsic value of options exercisable	$ 525,000	$ 374,000	$ 525,000	$ 374,000
2022 Employee Stock Option Plan
Options
Outstanding, beginning of year			130,000
Granted		10,000	0	10,000
Outstanding, end of period	130,000		130,000
Exercisable, end of period	28,000		28,000
Weighted average exercise price
Weighted average exercise price, beginning of year			$ 41.38
Weighted average exercise price, end of period	$ 41.38		41.38
Exercisable, end of period, weighted average exercise price	$ 39.96		$ 39.96
Additional disclosures
Total intrinsic value of options outstanding	$ 140,000		$ 140,000
Total intrinsic value of options exercisable	$ 56,000		$ 56,000

Stock Options - Exercise Price

Stock Options - Exercise Price Range (Details)	6 Months Ended
Stock Options - Exercise Price Range (Details)	Dec. 31, 2024 $ / shares shares
2012 Employee Stock Option Plan
Share based compensation, exercise prices
Options outstanding (in shares) \| shares	361,036
Weighted average remaining contractual life	6 years 7 months 24 days
Weighted average exercise price	$ 21.44
Number exercisable \| shares	265,660
Exercisable, Weighted average exercise price	$ 21.36
2012 Employee Stock Option Plan \| Exercise price range
Share based compensation, exercise prices
Exercise price upper limit	26.94
Exercise price lower limit	$ 10.02
2012 Non-Employee Stock Option Plan
Share based compensation, exercise prices
Options outstanding (in shares) \| shares	20,400
Weighted average remaining contractual life	5 years 1 month 20 days
Weighted average exercise price	$ 14.39
Number exercisable \| shares	18,480
Exercisable, Weighted average exercise price	$ 13.5
2012 Non-Employee Stock Option Plan \| Exercise price range
Share based compensation, exercise prices
Exercise price upper limit	22.93
Exercise price lower limit	$ 4.35
2018 Non-Employee Stock Option Plan
Share based compensation, exercise prices
Options outstanding (in shares) \| shares	64,900
Weighted average remaining contractual life	5 years 1 month 6 days
Weighted average exercise price	$ 14.02
Number exercisable \| shares	62,200
Exercisable, Weighted average exercise price	$ 13.63
2018 Non-Employee Stock Option Plan \| Exercise price range
Share based compensation, exercise prices
Exercise price upper limit	22.93
Exercise price lower limit	$ 8.1
2020 Non-Employee Stock Option Plan
Share based compensation, exercise prices
Options outstanding (in shares) \| shares	51,900
Weighted average remaining contractual life	7 years 10 days
Weighted average exercise price	$ 23
Number exercisable \| shares	37,520
Exercisable, Weighted average exercise price	$ 21.55
2020 Non-Employee Stock Option Plan \| Exercise price range
Share based compensation, exercise prices
Exercise price upper limit	30.71
Exercise price lower limit	$ 11.4
2022 Employee Stock Option Plan
Share based compensation, exercise prices
Options outstanding (in shares) \| shares	130,000
Weighted average remaining contractual life	9 years 3 months 18 days
Weighted average exercise price	$ 41.38
Number exercisable \| shares	28,000
Exercisable, Weighted average exercise price	$ 39.96
2022 Employee Stock Option Plan \| Exercise price range
Share based compensation, exercise prices
Exercise price upper limit	49.39
Exercise price lower limit	$ 21.6

Stockholders' Equity Transact_3

Stockholders' Equity Transactions (Details) - USD ($) $ / shares in Units, $ in Millions

1 Months Ended

3 Months Ended

6 Months Ended

Sep. 19, 2024

Dec. 19, 2024

Dec. 31, 2024

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Dec. 31, 2023

Sep. 30, 2023

Dec. 31, 2024

Nov. 30, 2024

Dec. 31, 2018

Sep. 16, 2014

Equity

Cash dividend declared (in dollars per share)

$ 0.125

$ 0.08

Authorized to be repurchased

$ 2

Authorized to be repurchased (in shares)

38,800,000

Authorized additional number of shares

1,000,000

Treasury stock shares acquired

193,252

282,647

193,252

475,899

Number of share available can be repurchased

1,104,741

Weighted average cost per share

$ 37.67

$ 37.95

$ 37.67

$ 37.84

O 2024 Q1 dividends

Equity

Dividends payable date declared

Aug. 18, 2023

Dividends payable date of record

Sep. 01, 2023

Dividends payable date to be paid

Sep. 22, 2023

Cash dividend declared (in dollars per share)

$ 0.08

O 2024 Q2 dividends

Equity

Dividends payable date declared

Nov. 02, 2023

Dividends payable date of record

Dec. 01, 2023

Dividends payable date to be paid

Dec. 22, 2023

Cash dividend declared (in dollars per share)

$ 0.08

O 2024 Q3 dividends

Equity

Dividends payable date declared

Feb. 01, 2024

Dividends payable date of record

Mar. 01, 2024

Dividends payable date to be paid

Mar. 22, 2024

Cash dividend declared (in dollars per share)

$ 0.1

O 2024 Q4 dividends

Equity

Dividends payable date declared

May 02, 2024

Dividends payable date of record

Jun. 03, 2024

Dividends payable date to be paid

Jun. 24, 2024

Cash dividend declared (in dollars per share)

$ 0.1

O 2025 Q1 dividends

Equity

Dividends payable date declared

Aug. 22, 2024

Dividends payable date of record

Sep. 12, 2024

Dividends payable date to be paid

Oct. 03, 2024

Cash dividend declared (in dollars per share)

$ 0.125

O 2025 Q2 dividends

Equity

Dividends payable date declared

Nov. 01, 2024

Dividends payable date of record

Dec. 12, 2024

Dividends payable date to be paid

Jan. 03, 2025

Cash dividend declared (in dollars per share)

$ 0.125

Certain employee and directors

Equity

Exercised

5,000

Exercised, cashless

3,000

Withheld (in shares)

2,151

Stockholders' Equity Transact_4

Stockholders' Equity Transactions - Shares repurchased (Details) - $ / shares		1 Months Ended	3 Months Ended		6 Months Ended
	Sep. 19, 2024	Dec. 19, 2024	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024
Stockholders' Equity Transactions
Total Number of Shares Purchased	193,252	282,647	282,647	193,252	475,899
Average Price Paid per Share	$ 37.67	$ 37.95	$ 37.95	$ 37.67	$ 37.84
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	193,252	282,647			475,899
Maximum Number of Shares that May Yet Be Purchased Under Plans or Programs	1,104,741	1,104,741	1,104,741		1,104,741

401(k) Plan (Details)

401(k) Plan (Details) - USD ($)	3 Months Ended		6 Months Ended
401(k) Plan (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
401(k) Plan
Employer contribution	$ 69,000	$ 58,000	$ 138,000	$ 119,000

Commitments and Contingencies -

Commitments and Contingencies - Leases (Details)			3 Months Ended		6 Months Ended
Commitments and Contingencies - Leases (Details)	Sep. 14, 2022 USD ($)	Sep. 13, 2022 USD ($)	Dec. 31, 2024 USD ($) a	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) a	Dec. 31, 2023 USD ($)
Commitments and Contingencies.
Operating lease term			99 years		99 years
Area of land \| a			4		4
Annual minimum rent	$ 235,000	$ 235,000
Annual service charges	$ 105,000	$ 53,000
Percentage of service charges increase	2%
Deduction of operating lease asset and liability, remeasurement	$ 1,300,000
Operating lease payments			$ 115,000	$ 86,000	$ 172,000	$ 171,000
Operating lease expense			$ 144,000	$ 129,000	$ 239,000	$ 253,000
Weighted-average remaining lease term			67 years		67 years
Weighted-average discount rate			6.25%		6.25%

Commitments and Contingencies_2

Commitments and Contingencies - Lease maturities (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Schedule, by years, of maturities of lease liabilities
2025	$ 172
2026	346
2027	349
2028	351
2029	353
Thereafter	29,665
Total future minimum lease payments	31,236
Less: Imputed interest	25,901
Operating lease liability	$ 5,335

Commitments and Contingencies_3

Commitments and Contingencies - Litigation, etc. (Details)	6 Months Ended
Commitments and Contingencies - Litigation, etc. (Details)	Dec. 31, 2024 USD ($) M agreement
Loss Contingencies
Number of employment agreement \| agreement	3
Number of severance agreement \| agreement	1
CEO
Loss Contingencies
Annual salary commitment \| $	$ 971,000
Termination pay commitment rate applied to the average of the prior five calendar years compensation	299%
Minimum number of months either party gives the other notice of non-renewal	6
Number of months of salary if terminated by the company without cause	9
Number of months of health insurance terminated benefit	6
SVP of Finance
Loss Contingencies
Annual salary commitment \| $	$ 350,000
Number of months of salary if terminated by the company without cause	6
Number of months of health insurance terminated benefit	6
SVP of Engineering
Loss Contingencies
Annual salary commitment \| $	$ 458,000
Number of months of salary if terminated by the company without cause	9
Number of months of health insurance terminated benefit	6

Geographical Data (Details)

Geographical Data (Details) $ in Thousands	3 Months Ended		6 Months Ended
Geographical Data (Details) $ in Thousands	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Jun. 30, 2024 USD ($)
Domestic and Foreign Operations
Number of operating segments (in segments) \| segment			1
Net Sales	$ 42,933	$ 47,547	$ 86,936	$ 89,223
Identifiable Assets	202,684		202,684		$ 207,752
United States
Domestic and Foreign Operations
Net Sales	42,679	47,291	86,367	88,661
Identifiable Assets	160,536		160,536		164,365
Foreign
Domestic and Foreign Operations
Net Sales	254	$ 256	569	$ 562
Dominican Republic
Domestic and Foreign Operations
Identifiable Assets	$ 42,148		$ 42,148		$ 43,387

Geographical Data - Additional

Geographical Data - Additional information (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024
Domestic and Foreign Operations
Inventories	$ 37,634	$ 34,804
Operating lease right of use	5,335	5,487
Fixed assets	9,915	9,077
Dominican Republic
Domestic and Foreign Operations
Inventories	31,864	33,584
Operating lease right of use	5,335	5,487
Fixed assets	$ 4,312	$ 3,623

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares shares in Millions	1 Months Ended	3 Months Ended
Subsequent Events (Details) - $ / shares shares in Millions	Jan. 30, 2025	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Sep. 16, 2014
Subsequent Event
Cash dividend declared (in dollars per share)		$ 0.125	$ 0.125	$ 0.08	$ 0.08
Authorized to be repurchased (in shares)						38.8
Subsequent Events \| O 2025 Q3 Dividends
Subsequent Event
Dividends payable date declared	Jan. 30, 2025
Cash dividend declared (in dollars per share)	$ 0.125
Dividends payable date to be paid	Apr. 03, 2025
Dividends payable date of record	Mar. 12, 2025